| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.664 | 0.009 | 0.664 | 12-Lipoxygenase inhibitor | 0.365 0.051 DB00244 0.389 0.042 DB00891 0.356 0.055 DBMET00924 0.406 0.038 DBMET03575 | ||
| 0.465 | 0.006 | 0.465 | Sodium/bile acid cotransporter inhibitor | 0.387 0.021 DB00244 0.409 0.015 DB00891 0.384 0.022 DBMET00924 0.409 0.014 DBMET03575 0.355 0.037 DBMET03576 | ||
| 0.497 | 0.041 | 0.497 | 15-Lipoxygenase inhibitor | 0.435 0.06 DB00244 0.392 0.078 DB00891 0.346 0.102 DBMET00924 0.377 0.085 DBMET03575 | ||
| 0.477 | 0.023 | 0.507 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.507 0.019 DB00244 0.334 0.055 DB00891 0.493 0.021 DBMET00924 0.278 0.07 DBMET03575 | DB00244 | |
| 0.423 | 0.004 | 0.607 | Hexokinase inhibitor | 0.329 0.008 DB00244 0.361 0.005 DB00891 0.351 0.006 DBMET00924 0.367 0.005 DBMET03575 0.607 0.002 DBMET03576 | DBMET03576 | |
| 0.413 | 0.005 | 0.413 | Alkaline phosphatase inhibitor | 0.215 0.028 DB00244 0.31 0.011 DB00891 0.181 0.042 DBMET00924 0.295 0.012 DBMET03575 0.334 0.008 DBMET03576 | ||
| 0.409 | 0.01 | 0.409 | Mcl-1 antagonist | 0.406 0.01 DB00244 0.182 0.066 DB00891 0.329 0.018 DBMET00924 0.185 0.064 DBMET03575 | ||
| 0.483 | 0.091 | 0.491 | DNA polymerase beta inhibitor | 0.325 0.152 DB00244 0.273 0.179 DB00891 0.491 0.089 DBMET00924 0.253 0.191 DBMET03575 | DBMET00924 | |
| 0.409 | 0.062 | 0.597 | Transcription factor NF kappa B inhibitor | 0.52 0.041 DB00244 0.212 0.157 DB00891 0.432 0.057 DBMET00924 0.238 0.137 DBMET03575 0.597 0.031 DBMET03576 | DBMET03576 | |
| 0.434 | 0.097 | 0.434 | Transcription factor inhibitor | 0.245 0.19 DB00244 0.244 0.191 DB00891 0.376 0.119 DBMET00924 | ||
| 0.433 | 0.103 | 0.489 | DNA directed DNA polymerase inhibitor | 0.356 0.135 DB00244 0.23 0.205 DB00891 0.489 0.086 DBMET00924 | DBMET00924 | |
| 0.332 | 0.006 | 0.625 | Carbonic anhydrase XV inhibitor | 0.625 0.002 DB00244 0.322 0.006 DB00891 0.427 0.004 DBMET00924 0.329 0.006 DBMET03575 | DB00244 | |
| 0.377 | 0.054 | 0.377 | Streptokinase A inhibitor | 0.288 0.084 DB00244 0.282 0.087 DBMET00924 | ||
| 0.304 | 0.005 | 0.385 | Carbonic anhydrase III inhibitor | 0.385 0.004 DB00244 0.22 0.013 DB00891 0.318 0.005 DBMET00924 0.247 0.009 DBMET03575 0.166 0.023 DBMET03576 | DB00244 | |
| 0.404 | 0.113 | 0.523 | Alpha-glucosidase inhibitor | 0.339 0.141 DB00244 0.221 0.205 DB00891 0.448 0.096 DBMET00924 0.269 0.176 DBMET03575 0.523 0.074 DBMET03576 | DBMET03576 | |
| 0.327 | 0.041 | 0.327 | Pyruvate kinase inhibitor | 0.291 0.05 DB00244 0.219 0.072 DBMET00924 | ||
| 0.324 | 0.042 | 0.457 | Transcription factor STAT3 inhibitor | 0.318 0.045 DB00244 0.457 0.01 DBMET00924 | DBMET00924 | |
| 0.302 | 0.026 | 0.339 | DNA methyltransferase I inhibitor | 0.339 0.016 DB00244 0.15 0.104 DB00891 0.331 0.017 DBMET00924 0.141 0.115 DBMET03575 0.283 0.033 DBMET03576 | DB00244 | |
| 0.272 | 0.008 | 0.377 | Catenin beta inhibitor | 0.377 0.004 DB00244 0.307 0.005 DBMET00924 | DB00244 | |
| 0.313 | 0.049 | 0.472 | Transcription factor STAT inhibitor | 0.329 0.042 DB00244 0.472 0.01 DBMET00924 | DBMET00924 | |
| 0.288 | 0.031 | 0.416 | Non-steroidal antiinflammatory agent | 0.362 0.018 DB00244 0.243 0.046 DB00891 0.276 0.034 DBMET00924 0.193 0.076 DBMET03575 0.416 0.012 DBMET03576 | DBMET03576 | |
| 0.268 | 0.017 | 0.279 | M17 leucyl aminopeptidase inhibitor | 0.243 0.022 DB00244 0.131 0.069 DB00891 0.279 0.015 DBMET00924 0.123 0.075 DBMET03575 | DBMET00924 | |
| 0.246 | 0.006 | 0.246 | Carbonic anhydrase XII inhibitor | 0.095 0.021 DB00244 0.15 0.013 DB00891 0.081 0.025 DBMET00924 0.124 0.016 DBMET03575 0.24 0.006 DBMET03576 | ||
| 0.235 | 0.005 | 0.296 | Electrolyte absorption antagonist | 0.296 0.004 DB00244 0.18 0.011 DB00891 0.26 0.005 DBMET00924 0.129 0.03 DBMET03575 | DB00244 | |
| 0.231 | 0.003 | 0.231 | Urate transporter 1 inhibitor | 0.103 0.005 DB00244 0.103 0.005 DB00891 0.078 0.008 DBMET00924 0.096 0.005 DBMET03575 | ||
| 0.251 | 0.025 | 0.376 | Histone acetyltransferase inhibitor | 0.211 0.054 DB00244 0.376 0.005 DB00891 0.325 0.01 DBMET03575 0.192 0.082 DBMET03576 | DB00891 | |
| 0.233 | 0.008 | 0.27 | HIV-1 integrase (3'-Processing) inhibitor | 0.27 0.005 DB00244 0.208 0.009 DBMET00924 0.08 0.034 DBMET03575 0.062 0.045 DBMET03576 | DB00244 | |
| 0.263 | 0.041 | 0.321 | DNA methylase inhibitor | 0.321 0.022 DB00244 0.142 0.124 DB00891 0.298 0.028 DBMET00924 0.273 0.037 DBMET03576 | DB00244 | |
| 0.258 | 0.038 | 0.415 | Dual specificity phosphatase 3 inhibitor | 0.415 0.012 DB00244 0.343 0.022 DBMET00924 | DB00244 | |
| 0.219 | 0.008 | 0.243 | HIV-1 integrase (Strand Transfer) inhibitor | 0.243 0.007 DB00244 0.165 0.012 DBMET00924 0.067 0.037 DBMET03575 0.054 0.046 DBMET03576 | DB00244 | |
| 0.247 | 0.039 | 0.362 | Focal adhesion kinase 2 inhibitor | 0.156 0.121 DB00244 0.362 0.005 DB00891 0.316 0.011 DBMET03575 | DB00891 | |
| 0.215 | 0.01 | 0.706 | Porphobilinogen synthase inhibitor | 0.706 0.002 DB00244 0.567 0.003 DBMET00924 | DB00244 | |
| 0.203 | 0.009 | 0.203 | Carbonic anhydrase inhibitor | 0.096 0.028 DB00244 0.154 0.015 DB00891 0.095 0.029 DBMET00924 0.169 0.013 DBMET03575 0.146 0.017 DBMET03576 | ||
| 0.252 | 0.058 | 0.3 | MAP-kinase-activated kinase 5 inhibitor | 0.3 0.03 DB00891 0.245 0.062 DBMET03575 | DB00891 | |
| 0.235 | 0.042 | 0.396 | Dual specificity phosphatase inhibitor | 0.396 0.015 DB00244 0.336 0.023 DBMET00924 | DB00244 | |
| 0.193 | 0.003 | 0.287 | Dihydropteroate synthase inhibitor | 0.198 0.002 DB00244 0.285 0.001 DB00891 0.146 0.004 DBMET00924 0.287 0.001 DBMET03575 0.065 0.01 DBMET03576 | DBMET03575 | |
| 0.231 | 0.041 | 0.416 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.127 0.095 DB00244 0.416 0.007 DB00891 0.405 0.008 DBMET03575 0.119 0.102 DBMET03576 | DB00891 | |
| 0.283 | 0.1 | 0.57 | Antithrombotic | 0.297 0.09 DB00244 0.313 0.08 DBMET00924 0.57 0.019 DBMET03576 | DBMET03576 | |
| 0.186 | 0.009 | 0.186 | Carbonic anhydrase IX inhibitor | 0.085 0.025 DB00244 0.141 0.013 DB00891 0.072 0.031 DBMET00924 0.105 0.019 DBMET03575 0.161 0.011 DBMET03576 | ||
| 0.179 | 0.005 | 0.18 | CC chemokine 6 receptor antagonist | 0.142 0.036 DB00244 0.18 0.005 DB00891 0.136 0.051 DBMET00924 0.172 0.007 DBMET03575 0.177 0.005 DBMET03576 | DB00891 | |
| 0.212 | 0.043 | 0.245 | Heat shock protein 90 alpha antagonist | 0.245 0.028 DB00244 0.218 0.04 DBMET00924 | DB00244 | |
| 0.182 | 0.016 | 0.262 | Uric acid excretion stimulant | 0.262 0.006 DB00244 0.22 0.01 DBMET00924 0.082 0.079 DBMET03576 | DB00244 | |
| 0.194 | 0.034 | 0.258 | Mannose-6-phosphate isomerase inhibitor | 0.258 0.01 DB00244 0.187 0.038 DB00891 0.169 0.05 DBMET00924 0.155 0.06 DBMET03575 0.168 0.05 DBMET03576 | DB00244 | |
| 0.185 | 0.026 | 0.348 | Cyclin-dependent kinase 9 inhibitor | 0.348 0.006 DB00891 0.344 0.007 DBMET03575 | DB00891 | |
| 0.252 | 0.099 | 0.335 | Lipoxygenase inhibitor | 0.335 0.056 DB00244 0.274 0.084 DBMET00924 | DB00244 | |
| 0.199 | 0.047 | 0.403 | Protein-tyrosine phosphatase inhibitor | 0.403 0.008 DB00244 0.331 0.014 DBMET00924 | DB00244 | |
| 0.186 | 0.04 | 0.217 | Cyclooxygenase 1 inhibitor | 0.217 0.028 DB00244 0.13 0.071 DB00891 0.123 0.077 DBMET00924 0.149 0.057 DBMET03575 0.118 0.083 DBMET03576 | DB00244 | |
| 0.165 | 0.019 | 0.197 | Caspase 3 inhibitor | 0.14 0.036 DB00244 0.197 0.01 DBMET00924 | DBMET00924 | |
| 0.166 | 0.02 | 0.39 | HIV-1 integrase (Overall Integration) inhibitor | 0.39 0.003 DB00244 0.112 0.045 DB00891 0.232 0.006 DBMET00924 0.114 0.044 DBMET03575 | DB00244 | |
| 0.185 | 0.048 | 0.185 | Cyclooxygenase inhibitor | 0.139 0.079 DB00244 0.152 0.068 DB00891 0.145 0.074 DBMET03575 0.124 0.094 DBMET03576 | ||
| 0.146 | 0.01 | 0.146 | Carbonic anhydrase II inhibitor | 0.075 0.027 DB00244 0.117 0.015 DB00891 0.076 0.027 DBMET00924 0.092 0.021 DBMET03575 0.091 0.021 DBMET03576 | ||
| 0.282 | 0.154 | 0.422 | MAP kinase kinase 6 inhibitor | 0.422 0.047 DB00891 0.289 0.146 DBMET03575 | DB00891 | |
| 0.198 | 0.075 | 0.266 | Insulin sensitizer | 0.266 0.026 DB00244 0.255 0.032 DBMET00924 0.153 0.129 DBMET03576 | DB00244 | |
| 0.175 | 0.054 | 0.188 | Cyclin-dependent kinase 3 inhibitor | 0.188 0.042 DB00891 0.16 0.076 DBMET00924 0.15 0.096 DBMET03575 | DB00891 | |
| 0.165 | 0.045 | 0.165 | Cyclooxygenase 2 inhibitor | 0.132 0.069 DB00891 0.12 0.08 DBMET03575 0.103 0.1 DBMET03576 | ||
| 0.132 | 0.012 | 0.132 | Carbonic anhydrase I inhibitor | 0.079 0.025 DB00244 0.102 0.018 DB00891 0.083 0.024 DBMET00924 0.078 0.026 DBMET03575 0.081 0.025 DBMET03576 | ||
| 0.161 | 0.041 | 0.372 | Interleukin 4 antagonist | 0.359 0.005 DB00244 0.372 0.005 DBMET00924 0.108 0.104 DBMET03576 | DBMET00924 | |
| 0.179 | 0.059 | 0.295 | ATPase inhibitor | 0.155 0.094 DB00244 0.167 0.075 DB00891 0.195 0.041 DBMET00924 0.157 0.09 DBMET03575 0.295 0.006 DBMET03576 | DBMET03576 | |
| 0.164 | 0.046 | 0.392 | Sodium channel (voltage-gated) blocker | 0.392 0.004 DB00891 0.323 0.006 DBMET03575 | DB00891 | |
| 0.127 | 0.01 | 0.262 | Purinergic P2X1 antagonist | 0.262 0.002 DB00244 0.191 0.004 DBMET00924 0.057 0.049 DBMET03575 | DB00244 | |
| 0.135 | 0.019 | 0.181 | Adrenaline agonist | 0.181 0.009 DB00244 0.098 0.039 DB00891 0.166 0.011 DBMET00924 0.114 0.028 DBMET03575 | DB00244 | |
| 0.122 | 0.007 | 0.17 | Glutamate (mGluR group III) agonist | 0.102 0.01 DB00244 0.17 0.004 DB00891 0.06 0.018 DBMET00924 0.066 0.016 DBMET03575 | DB00891 | |
| 0.129 | 0.017 | 0.154 | Purinergic P2X2 antagonist | 0.114 0.023 DB00244 0.066 0.048 DB00891 0.154 0.01 DBMET03575 0.087 0.036 DBMET03576 | DBMET03575 | |
| 0.128 | 0.02 | 0.168 | Carbonic anhydrase V inhibitor | 0.153 0.014 DB00244 0.168 0.011 DB00891 0.144 0.016 DBMET00924 0.16 0.012 DBMET03575 | DB00891 | |
| 0.18 | 0.072 | 0.327 | Amyloid beta precursor protein antagonist | 0.327 0.012 DB00244 0.272 0.025 DBMET00924 | DB00244 | |
| 0.312 | 0.205 | 0.67 | Antiinflammatory | 0.493 0.09 DB00244 0.384 0.149 DBMET00924 0.261 0.255 DBMET03575 0.67 0.037 DBMET03576 | DBMET03576 | |
| 0.122 | 0.018 | 0.157 | Carbonic anhydrase VA inhibitor | 0.138 0.013 DB00244 0.157 0.009 DB00891 0.132 0.015 DBMET00924 0.147 0.011 DBMET03575 | DB00891 | |
| 0.152 | 0.051 | 0.195 | M18 aspartyl aminopeptidase inhibitor | 0.195 0.035 DB00244 0.147 0.054 DBMET00924 | DB00244 | |
| 0.101 | 0.004 | 0.121 | Kynurenine 3 monooxygenase inhibitor | 0.045 0.008 DB00244 0.121 0.003 DB00891 0.087 0.004 DBMET03575 0.035 0.012 DBMET03576 | DB00891 | |
| 0.098 | 0.004 | 0.172 | Glutamate (mGluR4) agonist | 0.057 0.009 DB00244 0.172 0.003 DB00891 0.033 0.024 DBMET00924 0.063 0.008 DBMET03575 | DB00891 | |
| 0.121 | 0.029 | 0.31 | Carbonic anhydrase VI inhibitor | 0.31 0.006 DB00244 0.212 0.012 DB00891 0.155 0.02 DBMET00924 0.241 0.009 DBMET03575 0.137 0.024 DBMET03576 | DB00244 | |
| 0.247 | 0.158 | 0.247 | Beta lactamase inhibitor | 0.207 0.181 DB00891 0.225 0.17 DBMET00924 | ||
| 0.147 | 0.067 | 0.17 | MAP kinase kinase 4 inhibitor | 0.144 0.075 DB00244 0.17 0.033 DB00891 0.168 0.035 DBMET03575 | DB00891 | |
| 0.153 | 0.075 | 0.22 | Diuretic | 0.22 0.037 DB00244 0.124 0.1 DB00891 0.189 0.049 DBMET00924 0.184 0.052 DBMET03576 | DB00244 | |
| 0.214 | 0.136 | 0.284 | Hypoxia-inducible factor 1 alpha inhibitor | 0.284 0.074 DB00244 0.194 0.159 DBMET00924 | DB00244 | |
| 0.109 | 0.034 | 0.295 | Carbonic anhydrase XIII inhibitor | 0.295 0.006 DB00244 0.161 0.02 DB00891 0.185 0.016 DBMET00924 0.178 0.017 DBMET03575 0.237 0.01 DBMET03576 | DB00244 | |
| 0.08 | 0.006 | 0.134 | Endothelin receptor antagonist | 0.134 0.004 DB00891 0.094 0.005 DBMET03575 | DB00891 | |
| 0.148 | 0.076 | 0.258 | Phospholipase A2 inhibitor | 0.258 0.021 DB00244 0.244 0.025 DBMET00924 | DB00244 | |
| 0.091 | 0.019 | 0.17 | Carbonic anhydrase VB inhibitor | 0.141 0.01 DB00244 0.17 0.007 DB00891 0.08 0.023 DBMET00924 0.152 0.009 DBMET03575 | DB00891 | |
| 0.086 | 0.014 | 0.086 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.084 0.015 DB00244 0.059 0.03 DB00891 0.065 0.025 DBMET00924 0.083 0.015 DBMET03575 | ||
| 0.085 | 0.015 | 0.218 | Carbonic anhydrase XIV inhibitor | 0.218 0.004 DB00244 0.081 0.016 DB00891 0.143 0.005 DBMET00924 0.08 0.016 DBMET03575 0.142 0.005 DBMET03576 | DB00244 | |
| 0.137 | 0.068 | 0.439 | Sodium channel blocker | 0.439 0.004 DB00891 0.367 0.005 DBMET03575 | DB00891 | |
| 0.076 | 0.011 | 0.181 | Adenine nucleotide translocase inhibitor | 0.181 0.003 DB00244 0.154 0.003 DBMET00924 | DB00244 | |
| 0.145 | 0.081 | 0.2 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.2 0.018 DB00244 0.171 0.041 DBMET00924 | DB00244 | |
| 0.083 | 0.019 | 0.083 | Thromboxane antagonist | |||
| 0.244 | 0.183 | 0.584 | Antibacterial | 0.512 0.037 DB00244 0.446 0.058 DBMET00924 0.584 0.022 DBMET03576 | DBMET03576 | |
| 0.076 | 0.017 | 0.076 | Thromboxane A2 antagonist | |||
| 0.121 | 0.062 | 0.289 | Protein kinase (CK2) alpha inhibitor | 0.223 0.02 DB00244 0.289 0.012 DBMET00924 | DBMET00924 | |
| 0.076 | 0.021 | 0.122 | Transcription factor RelA inhibitor | 0.075 0.023 DB00244 0.122 0.004 DB00891 0.11 0.005 DBMET03575 | DB00891 | |
| 0.07 | 0.016 | 0.079 | Beta 2 adrenoreceptor antagonist | 0.059 0.025 DB00244 0.068 0.018 DB00891 0.064 0.021 DBMET00924 0.079 0.012 DBMET03575 | DBMET03575 | |
| 0.173 | 0.121 | 0.651 | Aldehyde oxidase inhibitor | 0.651 0.013 DB00244 0.162 0.129 DB00891 0.358 0.054 DBMET00924 0.281 0.072 DBMET03575 | DB00244 | |
| 0.063 | 0.013 | 0.091 | AICAR transformylase inhibitor | 0.091 0.006 DB00244 0.066 0.011 DB00891 0.072 0.009 DBMET00924 0.068 0.01 DBMET03575 | DB00244 | |
| 0.068 | 0.019 | 0.068 | Thromboxane synthase inhibitor | 0.053 0.042 DB00244 | ||
| 0.058 | 0.009 | 0.07 | Beta adrenoreceptor agonist | 0.07 0.005 DB00244 0.046 0.028 DB00891 0.07 0.005 DBMET00924 0.051 0.016 DBMET03575 | DBMET00924 | |
| 0.158 | 0.111 | 0.285 | I kappa B kinase epsilon inhibitor | 0.285 0.021 DB00244 0.19 0.08 DB00891 0.207 0.065 DBMET00924 0.148 0.121 DBMET03575 | DB00244 | |
| 0.082 | 0.036 | 0.119 | HIV-1 integrase inhibitor | 0.119 0.016 DB00244 0.098 0.026 DBMET00924 | DB00244 | |
| 0.107 | 0.062 | 0.151 | Cyclin-dependent kinase 1 inhibitor | 0.151 0.041 DB00891 0.116 0.057 DBMET03575 | DB00891 | |
| 0.104 | 0.061 | 0.252 | Protein kinase (CK2) inhibitor | 0.231 0.014 DB00244 0.252 0.011 DBMET00924 | DBMET00924 | |
| 0.061 | 0.019 | 0.152 | Carbonic anhydrase VII inhibitor | 0.106 0.009 DB00244 0.152 0.006 DBMET00924 | DBMET00924 | |
| 0.067 | 0.027 | 0.1 | Bombesin 3 receptor antagonist | 0.1 0.012 DB00891 0.068 0.026 DBMET03575 | DB00891 | |
| 0.045 | 0.007 | 0.097 | Endothelin A receptor antagonist | 0.097 0.004 DB00891 0.059 0.005 DBMET03575 | DB00891 | |
| 0.06 | 0.024 | 0.156 | Plasminogen activator inhibitor antagonist | 0.156 0.005 DB00244 0.121 0.007 DBMET00924 | DB00244 | |
| 0.039 | 0.006 | 0.039 | Prostaglandin H2 antagonist | 0.022 0.021 DB00891 | ||
| 0.13 | 0.097 | 0.141 | Thiol protease inhibitor | 0.138 0.082 DB00244 0.141 0.078 DBMET00924 | DBMET00924 | |
| 0.16 | 0.127 | 0.444 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.444 0.005 DB00244 0.395 0.008 DBMET00924 | DB00244 | |
| 0.104 | 0.074 | 0.274 | Protein-tyrosine phosphatase 1B inhibitor | 0.274 0.013 DB00244 0.236 0.019 DBMET00924 | DB00244 | |
| 0.062 | 0.033 | 0.073 | Bcl-xL inhibitor | 0.073 0.016 DB00891 0.067 0.024 DBMET03575 | DB00891 | |
| 0.188 | 0.16 | 0.298 | MAP kinase kinase 3 inhibitor | 0.236 0.047 DB00244 0.298 0.008 DB00891 0.235 0.048 DBMET03575 | DB00891 | |
| 0.068 | 0.041 | 0.089 | Beta adrenoreceptor antagonist | 0.077 0.03 DB00244 0.089 0.022 DBMET00924 0.071 0.037 DBMET03575 | DBMET00924 | |
| 0.07 | 0.042 | 0.106 | Bcl2 antagonist | 0.1 0.018 DB00891 0.106 0.015 DBMET03575 0.091 0.024 DBMET03576 | DBMET03575 | |
| 0.093 | 0.067 | 0.278 | Xanthine oxidase inhibitor | 0.278 0.009 DB00244 0.232 0.014 DBMET00924 | DB00244 | |
| 0.07 | 0.044 | 0.268 | Nav1.7 sodium channel blocker | 0.268 0.004 DB00891 0.201 0.005 DBMET03575 | DB00891 | |
| 0.05 | 0.025 | 0.05 | Purinergic P2X4 antagonist | 0.043 0.038 DB00891 0.045 0.034 DBMET00924 | ||
| 0.06 | 0.035 | 0.083 | Beta 1 adrenoreceptor antagonist | 0.055 0.041 DB00244 0.076 0.021 DB00891 0.066 0.03 DBMET00924 0.083 0.016 DBMET03575 | DBMET03575 | |
| 0.172 | 0.148 | 0.421 | RNA-directed DNA polymerase inhibitor | 0.421 0.016 DB00244 0.199 0.101 DB00891 0.266 0.041 DBMET00924 0.178 0.136 DBMET03575 | DB00244 | |
| 0.058 | 0.034 | 0.058 | Glucosylceramidase inhibitor | 0.057 0.035 DB00891 | ||
| 0.114 | 0.091 | 0.339 | NADPH oxidase inhibitor | 0.339 0.008 DB00244 0.29 0.014 DBMET00924 | DB00244 | |
| 0.109 | 0.086 | 0.322 | Nav1.3 sodium channel blocker | 0.322 0.007 DB00891 0.235 0.016 DBMET03575 | DB00891 | |
| 0.025 | 0.004 | 0.063 | CC chemokine 9 receptor antagonist | 0.063 0.002 DB00891 0.036 0.003 DBMET03575 | DB00891 | |
| 0.033 | 0.013 | 0.1 | NMDA 2D receptor antagonist | 0.1 0.004 DB00244 0.071 0.005 DBMET00924 | DB00244 | |
| 0.025 | 0.004 | 0.025 | Beta 3 adrenoreceptor agonist | 0.017 0.005 DB00244 0.021 0.005 DBMET00924 0.01 0.009 DBMET03575 | ||
| 0.028 | 0.009 | 0.047 | Beta 1 adrenoreceptor agonist | 0.045 0.004 DB00244 0.047 0.004 DBMET00924 0.023 0.015 DBMET03575 | DBMET00924 | |
| 0.195 | 0.177 | 0.27 | Thioredoxin glutathione reductase inhibitor | 0.186 0.184 DB00244 0.27 0.122 DBMET00924 | DBMET00924 | |
| 0.062 | 0.043 | 0.062 | Prostaglandin F2 alpha antagonist | |||
| 0.171 | 0.153 | 0.556 | Superoxide dismutase inhibitor | 0.556 0.009 DB00244 0.166 0.161 DB00891 0.385 0.029 DBMET00924 | DB00244 | |
| 0.034 | 0.017 | 0.034 | Cyclophilin A inhibitor | 0.032 0.019 DB00891 | ||
| 0.053 | 0.043 | 0.208 | Xanthine dehydrogenase inhibitor | 0.208 0.004 DB00244 0.146 0.008 DBMET00924 | DB00244 | |
| 0.036 | 0.027 | 0.062 | Integrin alpha2 antagonist | 0.05 0.012 DB00244 0.062 0.007 DB00891 0.059 0.007 DBMET03575 | DB00891 | |
| 0.053 | 0.044 | 0.136 | Potassium channel Kv1.5 blocker | 0.136 0.009 DB00891 0.056 0.04 DBMET03575 | DB00891 | |
| 0.026 | 0.02 | 0.05 | Integrin alpha2beta1 antagonist | 0.034 0.009 DB00244 0.05 0.004 DB00891 0.047 0.005 DBMET03575 | DB00891 | |
| 0.032 | 0.027 | 0.055 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.042 0.02 DB00244 0.032 0.027 DB00891 0.055 0.013 DBMET03575 | DBMET03575 | |
| 0.077 | 0.073 | 0.197 | Myeloperoxidase inhibitor | 0.197 0.005 DB00244 0.078 0.071 DB00891 0.092 0.046 DBMET00924 0.082 0.064 DBMET03575 | DB00244 | |
| 0.017 | 0.015 | 0.027 | Endothelin B receptor antagonist | 0.027 0.009 DB00891 0.018 0.014 DBMET03575 | DB00891 | |
| 0.183 | 0.181 | 0.562 | Cholesterol antagonist | 0.562 0.024 DB00244 0.466 0.038 DBMET00924 | DB00244 | |
| 0.184 | 0.182 | 0.348 | Insulysin inhibitor | 0.328 0.043 DB00244 0.196 0.163 DB00891 0.348 0.035 DBMET00924 | DBMET00924 | |
| 0.056 | 0.055 | 0.127 | I kappa B kinase 2 inhibitor | 0.07 0.032 DB00244 0.127 0.007 DB00891 0.092 0.016 DBMET03575 | DB00891 | |
| 0.022 | 0.021 | 0.048 | Methionyl aminopeptidase 2 inhibitor | 0.033 0.012 DB00244 0.048 0.007 DB00891 0.023 0.02 DBMET03575 | DB00891 | |
| 0.129 | 0.129 | 0.202 | Heat shock protein 70 antagonist | 0.202 0.006 DB00244 0.199 0.006 DBMET00924 | DB00244 | |
| 0.057 | 0.061 | 0.255 | Neuraminidase (influenza) inhibitor | 0.188 0.005 DB00244 0.255 0.004 DBMET00924 0.061 0.052 DBMET03576 | DBMET00924 | |
| 0.046 | 0.05 | 0.049 | Autotaxin inhibitor | 0.049 0.043 DB00244 | DB00244 | |
| 0.041 | 0.045 | 0.082 | CC chemokine 4 receptor antagonist | 0.082 0.006 DB00891 0.051 0.026 DBMET03575 | DB00891 | |
| 0.071 | 0.075 | 0.163 | I kappa B kinase inhibitor | 0.098 0.04 DB00244 0.163 0.013 DB00891 0.131 0.022 DBMET03575 | DB00891 | |
| 0.041 | 0.048 | 0.05 | Bromodomain-containing protein 3 inhibitor | 0.05 0.033 DB00891 | DB00891 | |
| 0.135 | 0.142 | 0.387 | Succinate dehydrogenase inhibitor | 0.387 0.004 DB00244 0.337 0.006 DBMET00924 | DB00244 | |
| 0.045 | 0.052 | 0.067 | Alpha 1b adrenoreceptor agonist | 0.067 0.013 DB00891 0.057 0.023 DBMET03575 | DB00891 | |
| 0.049 | 0.057 | 0.082 | Cyclin H inhibitor | 0.082 0.017 DB00891 0.062 0.036 DBMET03575 | DB00891 | |
| 0.024 | 0.033 | 0.054 | Purinergic P2Y14 antagonist | 0.049 0.007 DB00244 0.054 0.006 DBMET00924 | DBMET00924 | |
| 0.092 | 0.101 | 0.299 | Nav1.5 sodium channel blocker | 0.299 0.005 DB00891 0.185 0.016 DBMET03575 0.112 0.065 DBMET03576 | DB00891 | |
| 0.034 | 0.044 | 0.059 | Urokinase inhibitor | 0.059 0.028 DB00244 0.059 0.028 DB00891 0.046 0.035 DBMET03575 | DB00891 | |
| 0.032 | 0.041 | 0.049 | Retinoid X receptor antagonist | 0.049 0.013 DB00244 0.043 0.019 DBMET00924 | DB00244 | |
| 0.13 | 0.14 | 0.436 | Lipocortins synthesis antagonist | 0.436 0.006 DB00244 0.134 0.132 DB00891 0.271 0.027 DBMET00924 0.147 0.109 DBMET03575 0.149 0.107 DBMET03576 | DB00244 | |
| 0.048 | 0.058 | 0.251 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.233 0.003 DB00244 0.251 0.003 DBMET00924 | DBMET00924 | |
| 0.043 | 0.054 | 0.179 | Maillard reaction inhibitor | 0.179 0.004 DB00244 0.133 0.008 DBMET00924 | DB00244 | |
| 0.042 | 0.058 | 0.733 | Alcohol oxidase inhibitor | 0.733 0.003 DB00244 0.572 0.003 DBMET00924 | DB00244 | |
| 0.134 | 0.15 | 0.244 | Death-associated protein kinase 3 inhibitor | 0.143 0.133 DB00244 0.244 0.055 DB00891 0.195 0.077 DBMET03575 | DB00891 | |
| 0.123 | 0.139 | 0.25 | Antipruritic | 0.25 0.024 DB00891 0.221 0.036 DBMET03575 0.185 0.06 DBMET03576 | DB00891 | |
| 0.056 | 0.073 | 0.079 | Beta 2 adrenoreceptor agonist | 0.079 0.01 DB00244 0.077 0.011 DBMET00924 0.065 0.031 DBMET03575 | DB00244 | |
| 0.063 | 0.08 | 0.166 | Macrophage migration inhibitory factor inhibitor | 0.166 0.012 DB00244 0.094 0.038 DBMET00924 | DB00244 | |
| 0.064 | 0.081 | 0.318 | Keratolytic | 0.318 0.004 DB00244 0.282 0.004 DBMET00924 | DB00244 | |
| 0.013 | 0.03 | 0.08 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.019 0.018 DB00244 0.021 0.016 DB00891 0.08 0.004 DBMET03575 | DBMET03575 | |
| 0.094 | 0.112 | 0.19 | Interleukin 8 antagonist | 0.159 0.028 DB00244 0.19 0.015 DB00891 0.107 0.081 DBMET00924 0.155 0.031 DBMET03575 | DB00891 | |
| 0.027 | 0.045 | 0.041 | Retinoid X alpha receptor antagonist | 0.041 0.014 DB00244 0.037 0.019 DBMET00924 | DB00244 | |
| 0.003 | 0.022 | 0.009 | Insulin like growth factor 3 antagonist | 0.009 0.003 DB00244 | DB00244 | |
| 0.002 | 0.021 | 0.007 | Glucokinase regulatory protein inhibitor | 0.007 0.002 DB00891 0.005 0.003 DBMET03575 | DB00891 | |
| 0.007 | 0.027 | 0.02 | Retinoic acid beta receptor antagonist | 0.02 0.004 DB00244 0.015 0.005 DBMET00924 | DB00244 | |
| 0.033 | 0.053 | 0.077 | GHS receptor agonist | 0.077 0.007 DB00891 0.054 0.017 DBMET03575 | DB00891 | |
| 0.045 | 0.065 | 0.258 | Neuraminidase inhibitor | 0.178 0.005 DB00244 0.258 0.003 DBMET00924 | DBMET00924 | |
| 0.165 | 0.186 | 0.336 | Prostaglandin dehydrogenase inhibitor | 0.336 0.088 DB00244 0.234 0.135 DBMET00924 | DB00244 | |
| 0.074 | 0.095 | 0.1 | Bromodomain-containing protein 2 inhibitor | 0.1 0.04 DB00891 | DB00891 | |
| 0.019 | 0.041 | 0.031 | CC chemokine 8 receptor antagonist | 0.031 0.005 DB00891 0.023 0.017 DBMET03575 | DB00891 | |
| 0.017 | 0.039 | 0.029 | CXC chemokine 2 receptor antagonist | 0.027 0.018 DB00891 0.029 0.015 DBMET03575 | DBMET03575 | |
| 0.039 | 0.062 | 0.194 | Topoisomerase II beta inhibitor | 0.194 0.004 DB00244 0.161 0.005 DBMET00924 | DB00244 | |
| 0.052 | 0.077 | 0.095 | Prostaglandin-E synthase inhibitor | 0.095 0.029 DBMET00924 | DBMET00924 | |
| 0.021 | 0.046 | 0.066 | Myristoyl transferase inhibitor | 0.066 0.004 DB00891 0.026 0.021 DBMET03575 | DB00891 | |
| 0.036 | 0.062 | 0.049 | Carnitine palmitoyltransferase 1B inhibitor | 0.048 0.033 DB00244 0.049 0.031 DBMET00924 | DBMET00924 | |
| 0.051 | 0.077 | 0.111 | CDK1/cyclin B1 inhibitor | 0.111 0.025 DB00891 0.079 0.039 DBMET03575 | DB00891 | |
| 0.049 | 0.076 | 0.272 | Phenylalanine 4-hydroxylase inhibitor | 0.272 0.004 DB00244 0.146 0.012 DBMET00924 | DB00244 | |
| 0.081 | 0.109 | 0.142 | Beta glucuronidase inhibitor | 0.113 0.053 DB00244 0.112 0.054 DBMET00924 0.142 0.029 DBMET03576 | DBMET03576 | |
| 0.007 | 0.036 | 0.021 | Retinoic acid receptor gamma antagonist | 0.021 0.004 DB00244 0.014 0.005 DBMET00924 | DB00244 | |
| 0.022 | 0.051 | 0.083 | Phosphoglycerate kinase inhibitor | 0.083 0.008 DB00244 0.044 0.016 DBMET00924 | DB00244 | |
| 0.071 | 0.101 | 0.262 | D-Ala-D-Ala ligase inhibitor | 0.262 0.002 DB00244 0.17 0.004 DBMET00924 0.091 0.043 DBMET03575 | DB00244 | |
| 0.005 | 0.035 | 0.011 | 2-Acylglycerol O-acyltransferase 2 inhibitor | 0.011 0.006 DB00891 | DB00891 | |
| 0.127 | 0.158 | 0.259 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.259 0.064 DB00244 0.16 0.122 DBMET00924 0.218 0.082 DBMET03575 | DB00244 | |
| 0.07 | 0.101 | 0.309 | Alcohol dehydrogenase inhibitor | 0.309 0.005 DB00244 0.21 0.011 DBMET00924 | DB00244 | |
| 0.077 | 0.108 | 0.112 | Cyclin-dependent kinase 2 inhibitor | 0.112 0.058 DB00891 | DB00891 | |
| 0.218 | 0.25 | 0.726 | Cyclophilin D inhibitor | 0.339 0.13 DB00244 0.267 0.194 DBMET00924 0.726 0.012 DBMET03576 | DBMET03576 | |
| 0.11 | 0.141 | 0.221 | Protein kinase (CK1) gamma 3 inhibitor | 0.221 0.037 DB00891 0.211 0.041 DBMET03575 | DB00891 | |
| 0.01 | 0.042 | 0.033 | Retinoic acid receptor antagonist | 0.033 0.005 DB00244 0.025 0.008 DBMET00924 | DB00244 | |
| 0.023 | 0.056 | 0.045 | Purinergic P2Y2 antagonist | 0.045 0.012 DB00244 0.034 0.023 DBMET00924 | DB00244 | |
| 0.052 | 0.085 | 0.093 | Beta 3 adrenoreceptor antagonist | 0.074 0.029 DB00244 0.064 0.045 DB00891 0.093 0.017 DBMET00924 0.073 0.03 DBMET03575 | DBMET00924 | |
| 0.032 | 0.066 | 0.18 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.18 0.002 DB00244 0.076 0.004 DBMET00924 0.038 0.037 DBMET03575 | DB00244 | |
| 0.064 | 0.099 | 0.134 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.134 0.019 DB00244 0.122 0.024 DBMET00924 | DB00244 | |
| 0.086 | 0.122 | 0.148 | CDK3/cyclin E inhibitor | 0.122 0.053 DB00891 0.148 0.028 DBMET00924 0.111 0.068 DBMET03575 | DBMET00924 | |
| 0.037 | 0.073 | 0.101 | CDK9/cyclin T1 inhibitor | 0.101 0.019 DB00891 0.064 0.036 DBMET03575 | DB00891 | |
| 0.01 | 0.046 | 0.017 | Factor IX inhibitor | 0.017 0.015 DB00891 | DB00891 | |
| 0.051 | 0.088 | 0.245 | Potassium channel large-conductance Ca-activated activator | 0.245 0.005 DB00244 0.123 0.016 DBMET00924 | DB00244 | |
| 0.023 | 0.06 | 0.048 | RNA-directed RNA polymerase inhibitor | 0.048 0.014 DB00244 0.037 0.021 DBMET00924 | DB00244 | |
| 0.01 | 0.049 | 0.033 | CDK2/cyclin A3 inhibitor | 0.033 0.003 DB00891 0.021 0.005 DBMET03575 | DB00891 | |
| 0.05 | 0.09 | 0.059 | Trypsin inhibitor | 0.059 0.049 DB00891 | DB00891 | |
| 0.021 | 0.061 | 0.098 | Nicotinic acid receptor 2 agonist | 0.09 0.007 DB00244 0.098 0.005 DBMET00924 0.04 0.02 DBMET03575 | DBMET00924 | |
| 0.01 | 0.05 | 0.036 | Retinoic acid alpha receptor antagonist | 0.036 0.005 DB00244 0.029 0.007 DBMET00924 | DB00244 | |
| 0.042 | 0.083 | 0.084 | DNA helicase inhibitor | 0.073 0.015 DB00244 0.084 0.01 DBMET00924 | DBMET00924 | |
| 0.076 | 0.117 | 0.269 | Chelator | 0.269 0.014 DB00244 0.218 0.021 DBMET00924 | DB00244 | |
| 0.067 | 0.109 | 0.137 | Transcription factor NF kappa B stimulant | 0.137 0.019 DBMET03576 | DBMET03576 | |
| 0.032 | 0.074 | 0.072 | Glutamate (mGluR4) antagonist | 0.072 0.01 DB00244 0.042 0.034 DBMET00924 | DB00244 | |
| 0.125 | 0.168 | 0.534 | Phospholipase C inhibitor | 0.534 0.005 DB00244 0.139 0.131 DB00891 0.328 0.016 DBMET00924 0.143 0.121 DBMET03575 | DB00244 | |
| 0.021 | 0.065 | 0.069 | Carbonic anhydrase IV inhibitor | 0.039 0.034 DB00244 0.069 0.015 DB00891 0.044 0.029 DBMET00924 0.05 0.025 DBMET03575 | DB00891 | |
| 0.076 | 0.119 | 0.254 | AMP-activated protein kinase stimulant | 0.172 0.017 DB00244 0.16 0.022 DBMET00924 0.254 0.006 DBMET03576 | DBMET03576 | |
| 0.014 | 0.057 | 0.042 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.031 0.007 DB00244 0.042 0.004 DB00891 0.035 0.005 DBMET03575 | DB00891 | |
| 0.018 | 0.062 | 0.028 | Retinoid X gamma receptor antagonist | 0.028 0.016 DB00244 | DB00244 | |
| 0.077 | 0.122 | 0.157 | Histone deacetylase class III inhibitor | 0.118 0.071 DB00244 0.157 0.038 DBMET00924 | DBMET00924 | |
| 0.046 | 0.092 | 0.075 | ZAP-70 protein tyrosine kinase inhibitor | 0.075 0.042 DB00891 | DB00891 | |
| 0.119 | 0.164 | 0.273 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.273 0.05 DB00891 0.198 0.076 DBMET03575 | DB00891 | |
| 0.014 | 0.06 | 0.05 | 5 Hydroxytryptamine 1F agonist | 0.05 0.005 DB00891 0.028 0.014 DBMET03575 | DB00891 | |
| 0.02 | 0.069 | 0.068 | Estradiol 17 beta-dehydrogenase inhibitor | 0.049 0.025 DB00244 0.068 0.016 DBMET03575 | DBMET03575 | |
| 0.015 | 0.064 | 0.039 | HCV NS5B polymerase inhibitor | 0.039 0.015 DB00244 0.028 0.026 DBMET00924 | DB00244 | |
| 0.04 | 0.09 | 0.162 | Dihydroorotate oxidase inhibitor | 0.131 0.003 DB00244 0.162 0.002 DBMET00924 | DBMET00924 | |
| 0.014 | 0.066 | 0.035 | Retinoic acid gamma receptor agonist | 0.035 0.005 DB00244 0.03 0.007 DBMET00924 | DB00244 | |
| 0.022 | 0.075 | 0.068 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.068 0.02 DB00891 0.056 0.025 DBMET03575 | DB00891 | |
| 0.027 | 0.08 | 0.083 | Fructose-1,6-bisphosphatase inhibitor | 0.071 0.012 DB00244 0.083 0.006 DB00891 0.071 0.012 DBMET03575 | DB00891 | |
| 0.04 | 0.094 | 0.11 | Leukotriene antagonist | 0.11 0.018 DB00244 0.093 0.025 DBMET00924 | DB00244 | |
| 0.121 | 0.175 | 0.251 | Dyrk kinase inhibitor | 0.251 0.071 DB00244 0.149 0.137 DBMET00924 0.217 0.089 DBMET03575 | DB00244 | |
| 0.142 | 0.195 | 0.582 | Hypoglycemic | 0.247 0.079 DB00244 0.178 0.137 DBMET00924 0.582 0.009 DBMET03576 | DBMET03576 | |
| 0.036 | 0.091 | 0.049 | Carbonic anhydrase II stimulant | 0.049 0.041 DB00891 | DB00891 | |
| 0.01 | 0.065 | 0.026 | Retinoid X gamma receptor agonist | 0.026 0.013 DB00244 | DB00244 | |
| 0.004 | 0.061 | 0.02 | Thrombopoietin agonist | 0.017 0.005 DB00244 0.02 0.004 DBMET00924 | DBMET00924 | |
| 0.037 | 0.095 | 0.288 | Phosphofructokinase-1 inhibitor | 0.288 0.006 DB00244 0.157 0.017 DBMET00924 0.094 0.034 DBMET03576 | DB00244 | |
| 0.04 | 0.098 | 0.056 | Sphingosine 1-phosphate receptor 1 antagonist | 0.056 0.038 DBMET00924 | DBMET00924 | |
| 0.019 | 0.078 | 0.03 | Caspase 6 inhibitor | 0.03 0.021 DBMET00924 | DBMET00924 | |
| 0.074 | 0.133 | 0.382 | Amylase inhibitor | 0.303 0.018 DB00244 0.159 0.06 DBMET00924 0.127 0.077 DBMET03575 0.382 0.01 DBMET03576 | DBMET03576 | |
| 0.036 | 0.096 | 0.438 | CD45 antagonist | 0.438 0.003 DB00244 0.298 0.004 DBMET00924 | DB00244 | |
| 0.036 | 0.096 | 0.1 | Heparanase inhibitor | 0.075 0.009 DB00244 0.1 0.004 DBMET00924 0.072 0.01 DBMET03576 | DBMET00924 | |
| 0.089 | 0.149 | 0.244 | Protein kinase (CK1) gamma 1 inhibitor | 0.244 0.03 DB00891 0.204 0.041 DBMET03575 | DB00891 | |
| 0.059 | 0.12 | 0.163 | Urease inhibitor | 0.153 0.022 DB00244 0.163 0.018 DBMET00924 | DBMET00924 | |
| 0.017 | 0.079 | 0.032 | ATP citrate lysase inhibitor | 0.032 0.022 DB00244 | DB00244 | |
| 0.032 | 0.094 | 0.144 | Aconitate hydratase inhibitor | 0.144 0.004 DB00244 0.067 0.02 DBMET00924 | DB00244 | |
| 0.01 | 0.074 | 0.043 | Leukotriene B4 receptor 1 antagonist | 0.043 0.01 DB00244 | DB00244 | |
| 0.054 | 0.118 | 0.409 | Monophenol monooxygenase inhibitor | 0.409 0.011 DB00244 0.326 0.015 DBMET00924 | DB00244 | |
| 0.005 | 0.07 | 0.013 | 5 Lipoxygenase activating protein inhibitor | 0.013 0.011 DB00891 | DB00891 | |
| 0.044 | 0.108 | 0.297 | Glutamate decarboxylase inhibitor | 0.297 0.004 DB00244 0.175 0.009 DBMET00924 | DB00244 | |
| 0.072 | 0.137 | 0.167 | Protein kinase C gamma inhibitor | 0.167 0.023 DB00244 0.097 0.082 DB00891 0.113 0.059 DBMET00924 | DB00244 | |
| 0.081 | 0.147 | 0.343 | Nav1.6 sodium channel blocker | 0.343 0.005 DB00891 0.27 0.008 DBMET03575 | DB00891 | |
| 0.063 | 0.129 | 0.416 | UDP-glucose 4-epimerase inhibitor | 0.397 0.006 DB00244 0.416 0.005 DBMET00924 0.112 0.049 DBMET03576 | DBMET00924 | |
| 0.037 | 0.103 | 0.081 | HIV-1 reverse transcriptase inhibitor | 0.081 0.041 DB00244 | DB00244 | |
| 0.018 | 0.084 | 0.041 | Carnitine palmitoyltransferase 1 inhibitor | 0.041 0.014 DBMET00924 | DBMET00924 | |
| 0.007 | 0.074 | 0.043 | Nicotinic acid receptor 1 antagonist | 0.036 0.004 DB00244 0.043 0.003 DBMET00924 | DBMET00924 | |
| 0.029 | 0.097 | 0.061 | DNA gyrase subunit A inhibitor | 0.061 0.01 DB00244 0.047 0.021 DBMET00924 | DB00244 | |
| 0.045 | 0.113 | 0.084 | Thrombin inhibitor | 0.084 0.037 DB00891 0.069 0.056 DBMET03575 | DB00891 | |
| 0.076 | 0.144 | 0.257 | DOPA decarboxylase inhibitor | 0.257 0.004 DB00244 0.171 0.013 DBMET00924 | DB00244 | |
| 0.047 | 0.119 | 0.224 | Glutamate dehydrogenase inhibitor | 0.224 0.008 DB00244 0.148 0.016 DBMET00924 | DB00244 | |
| 0.065 | 0.137 | 0.383 | Cystathionine beta-synthase inhibitor | 0.383 0.005 DB00244 0.208 0.023 DBMET00924 | DB00244 | |
| 0.057 | 0.131 | 0.168 | Chemokine receptor antagonist | 0.168 0.026 DB00891 0.099 0.064 DBMET03575 | DB00891 | |
| 0.068 | 0.142 | 0.147 | Cyclin-dependent kinase inhibitor | 0.147 0.058 DB00891 0.106 0.084 DBMET03575 | DB00891 | |
| 0.165 | 0.24 | 0.424 | 5 Hydroxytryptamine uptake stimulant | 0.424 0.01 DB00244 0.342 0.028 DBMET00924 | DB00244 | |
| 0.119 | 0.194 | 0.377 | Free radical scavenger | 0.377 0.033 DB00244 0.298 0.052 DBMET00924 0.352 0.038 DBMET03576 | DB00244 | |
| 0.011 | 0.087 | 0.039 | Retinoic acid receptor agonist | 0.039 0.007 DB00244 0.035 0.008 DBMET00924 | DB00244 | |
| 0.019 | 0.095 | 0.03 | LIM domain kinase 2 inhibitor | 0.03 0.024 DB00891 | DB00891 | |
| 0.106 | 0.182 | 0.161 | Pregnane X receptor agonist | 0.161 0.035 DB00891 0.149 0.054 DBMET03575 | DB00891 | |
| 0.016 | 0.092 | 0.065 | 5 Hydroxytryptamine 6 agonist | 0.065 0.004 DB00891 0.03 0.017 DBMET03575 | DB00891 | |
| 0.016 | 0.092 | 0.042 | Carnitine palmitoyltransferase inhibitor | 0.042 0.014 DBMET00924 | DBMET00924 | |
| 0.033 | 0.11 | 0.078 | Carbonic anhydrase stimulant | 0.078 0.027 DB00891 0.057 0.044 DBMET03575 | DB00891 | |
| 0.058 | 0.135 | 0.082 | Aminoacyl-tRNA synthetase inhibitor | 0.082 0.074 DB00244 | DB00244 | |
| 0.043 | 0.121 | 0.119 | CC chemokine receptor antagonist | 0.119 0.027 DB00891 0.08 0.051 DBMET03575 | DB00891 | |
| 0.047 | 0.125 | 0.078 | CDC25A inhibitor | 0.078 0.046 DB00244 | DB00244 | |
| 0.027 | 0.105 | 0.045 | CDK7/cyclin H inhibitor | 0.045 0.032 DB00891 | DB00891 | |
| 0.012 | 0.091 | 0.023 | Retinoid X beta receptor antagonist | 0.023 0.009 DB00244 | DB00244 | |
| 0.01 | 0.089 | 0.017 | CC chemokine 10 receptor antagonist | 0.017 0.006 DB00891 | DB00891 | |
| 0.083 | 0.163 | 0.613 | Peroxidase inhibitor | 0.613 0.004 DB00244 0.183 0.064 DB00891 0.445 0.015 DBMET00924 0.198 0.06 DBMET03575 | DB00244 | |
| 0.054 | 0.135 | 0.141 | CDK2/cyclin A inhibitor | 0.141 0.03 DB00891 0.098 0.06 DBMET03575 | DB00891 | |
| 0.04 | 0.121 | 0.069 | Histone deacetylase SIRT2 inhibitor | 0.069 0.057 DBMET00924 | DBMET00924 | |
| 0.046 | 0.128 | 0.097 | Bcr-Abl kinase inhibitor | 0.086 0.056 DB00244 0.097 0.044 DBMET00924 | DBMET00924 | |
| 0.067 | 0.15 | 0.226 | Toll-Like receptor 3 antagonist | 0.141 0.018 DB00244 0.226 0.005 DB00891 0.132 0.022 DBMET03575 | DB00891 | |
| 0.025 | 0.109 | 0.107 | Phosphatidylinositol 3-kinase beta inhibitor | 0.107 0.011 DB00891 0.087 0.015 DBMET03575 | DB00891 | |
| 0.073 | 0.157 | 0.095 | Folate antagonist | 0.095 0.075 DB00244 | DB00244 | |
| 0.059 | 0.145 | 0.324 | NADH dehydrogenase inhibitor | 0.324 0.006 DB00244 0.158 0.016 DBMET00924 0.082 0.071 DBMET03575 0.138 0.021 DBMET03576 | DB00244 | |
| 0.029 | 0.116 | 0.101 | Leukotriene B4 antagonist | 0.101 0.01 DB00244 0.059 0.03 DBMET00924 | DB00244 | |
| 0.035 | 0.121 | 0.078 | Factor III inhibitor | 0.078 0.008 DB00244 0.065 0.014 DBMET00924 | DB00244 | |
| 0.009 | 0.095 | 0.06 | Factor X inhibitor | 0.06 0.018 DB00891 | DB00891 | |
| 0.037 | 0.124 | 0.077 | CDC25B inhibitor | 0.077 0.031 DB00244 0.057 0.055 DBMET00924 | DB00244 | |
| 0.05 | 0.137 | 0.18 | Aminopeptidase B inhibitor | 0.18 0.026 DB00244 0.15 0.038 DBMET00924 | DB00244 | |
| 0.048 | 0.135 | 0.087 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.031 DB00244 0.087 0.025 DB00891 | DB00891 | |
| 0.021 | 0.11 | 0.06 | Protein kinase (CK2) beta inhibitor | 0.06 0.005 DB00244 0.044 0.01 DBMET00924 | DB00244 | |
| 0.028 | 0.117 | 0.064 | CDK1/cyclin B inhibitor | 0.064 0.043 DB00891 | DB00891 | |
| 0.013 | 0.102 | 0.214 | Kainate receptor antagonist | 0.214 0.004 DB00244 0.064 0.014 DBMET00924 | DB00244 | |
| 0.022 | 0.113 | 0.063 | Plasminogen activator inhibitor | 0.056 0.043 DB00244 0.063 0.037 DBMET00924 | DBMET00924 | |
| 0.057 | 0.148 | 0.303 | Triose-phosphate isomerase inhibitor | 0.303 0.005 DB00244 0.223 0.009 DBMET00924 0.092 0.057 DBMET03576 | DB00244 | |
| 0.03 | 0.121 | 0.087 | Cyclin A2 inhibitor | 0.087 0.029 DB00891 | DB00891 | |
| 0.023 | 0.115 | 0.134 | Glutamate (mGluR8) agonist | 0.134 0.002 DB00244 0.079 0.004 DBMET00924 | DB00244 | |
| 0.02 | 0.112 | 0.071 | Retinoic acid alpha receptor agonist | 0.071 0.006 DB00244 0.059 0.009 DBMET00924 | DB00244 | |
| 0.024 | 0.117 | 0.07 | Raf kinase B inhibitor | 0.07 0.034 DB00891 | DB00891 | |
| 0.09 | 0.184 | 0.202 | Heat shock protein 90 antagonist | 0.202 0.037 DB00244 0.153 0.072 DBMET00924 | DB00244 | |
| 0.09 | 0.185 | 0.205 | Farnesoid X receptor antagonist | 0.205 0.02 DB00244 0.18 0.029 DBMET00924 | DB00244 | |
| 0.057 | 0.152 | 0.605 | GABA C receptor agonist | 0.605 0.003 DB00244 0.283 0.01 DBMET00924 | DB00244 | |
| 0.007 | 0.103 | 0.022 | Retinoid X beta receptor agonist | 0.022 0.013 DB00244 | DB00244 | |
| 0.032 | 0.129 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.053 0.049 DB00244 0.056 0.043 DB00891 | DB00891 | |
| 0.077 | 0.174 | 0.171 | Cytidine deaminase inhibitor | 0.114 0.108 DB00244 0.171 0.061 DBMET00924 | DBMET00924 | |
| 0.043 | 0.141 | 0.348 | Potassium channel (Ca-activated) activator | 0.348 0.004 DB00244 0.195 0.015 DBMET00924 | DB00244 | |
| 0.012 | 0.11 | 0.15 | Nicotinic acid receptor agonist | 0.11 0.004 DB00244 0.15 0.004 DBMET00924 | DBMET00924 | |
| 0.19 | 0.29 | 0.466 | Apoptosis agonist | 0.372 0.128 DB00244 0.307 0.167 DBMET00924 0.466 0.085 DBMET03576 | DBMET03576 | |
| 0.015 | 0.115 | 0.058 | Purinergic P2Y antagonist | 0.058 0.02 DB00244 0.044 0.033 DBMET00924 | DB00244 | |
| 0.06 | 0.161 | 0.121 | ABCA1 expression enhancer | 0.121 0.03 DB00244 0.09 0.066 DBMET00924 | DB00244 | |
| 0.042 | 0.143 | 0.096 | I kappa B kinase 1 inhibitor | 0.096 0.025 DB00891 0.07 0.048 DBMET03575 | DB00891 | |
| 0.004 | 0.106 | 0.022 | Carbonic anhydrase X inhibitor | 0.022 0.007 DBMET00924 | DBMET00924 | |
| 0.004 | 0.106 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 DBMET00924 | DBMET00924 | |
| 0.037 | 0.141 | 0.109 | Aminopeptidase I inhibitor | 0.109 0.023 DB00244 0.091 0.033 DBMET00924 | DB00244 | |
| 0.053 | 0.157 | 0.14 | GABA B receptor agonist | 0.14 0.005 DB00244 0.121 0.007 DBMET00924 | DB00244 | |
| 0.042 | 0.148 | 0.127 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.127 0.036 DB00891 | DB00891 | |
| 0.01 | 0.117 | 0.025 | Retinoic acid beta receptor agonist | 0.025 0.008 DB00244 0.021 0.012 DBMET00924 | DB00244 | |
| 0.031 | 0.14 | 0.081 | Raf kinase inhibitor | 0.081 0.044 DB00891 | DB00891 | |
| 0.026 | 0.134 | 0.078 | Cyclin A inhibitor | 0.078 0.033 DB00891 | DB00891 | |
| 0.011 | 0.12 | 0.035 | Factor XIII inhibitor | 0.035 0.004 DB00891 0.021 0.014 DBMET03575 | DB00891 | |
| 0.067 | 0.178 | 0.276 | Adenylate kinase inhibitor | 0.276 0.008 DB00244 0.15 0.026 DBMET00924 | DB00244 | |
| 0.04 | 0.153 | 0.07 | Leukotriene C antagonist | 0.062 0.024 DB00244 0.07 0.014 DBMET00924 | DBMET00924 | |
| 0.008 | 0.122 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 DB00244 | DB00244 | |
| 0.096 | 0.211 | 0.29 | Interferon gamma antagonist | 0.29 0.021 DB00244 0.248 0.029 DBMET00924 0.13 0.112 DBMET03576 | DB00244 | |
| 0.027 | 0.141 | 0.071 | Glutamate (mGluR group III) antagonist | 0.071 0.009 DB00244 | DB00244 | |
| 0.019 | 0.134 | 0.059 | Alpha tubulin antagonist | 0.059 0.031 DB00244 | DB00244 | |
| 0.026 | 0.144 | 0.064 | Bromodomain-containing protein 4 inhibitor | 0.064 0.029 DB00891 | DB00891 | |
| 0.03 | 0.149 | 0.477 | Histidine decarboxylase inhibitor | 0.477 0.003 DB00244 0.317 0.005 DBMET00924 | DB00244 | |
| 0.066 | 0.186 | 0.201 | Protein kinase (CK1) gamma inhibitor | 0.201 0.044 DB00891 0.185 0.05 DBMET03575 | DB00891 | |
| 0.077 | 0.197 | 0.295 | Amyloid beta aggregation inhibitor | 0.295 0.046 DB00244 0.198 0.079 DBMET00924 | DB00244 | |
| 0.049 | 0.17 | 0.269 | Creatine kinase inhibitor | 0.269 0.005 DB00244 0.195 0.011 DBMET00924 0.088 0.075 DBMET03575 | DB00244 | |
| 0.091 | 0.212 | 0.33 | MAP kinase kinase 2 inhibitor | 0.263 0.048 DB00244 0.33 0.026 DB00891 0.164 0.109 DBMET00924 0.299 0.035 DBMET03575 | DB00891 | |
| 0.012 | 0.133 | 0.041 | Factor VIIa inhibitor | 0.041 0.024 DB00244 | DB00244 | |
| 0.025 | 0.148 | 0.047 | Leukotriene C4 antagonist | 0.041 0.023 DB00244 0.047 0.013 DBMET00924 | DBMET00924 | |
| 0.024 | 0.148 | 0.229 | Biliverdin reductase inhibitor | 0.229 0.005 DB00244 0.142 0.01 DBMET00924 | DB00244 | |
| 0.102 | 0.228 | 0.239 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.239 0.055 DB00891 0.222 0.063 DBMET03575 | DB00891 | |
| 0.003 | 0.132 | 0.014 | Carbonic anhydrase XI inhibitor | 0.014 0.007 DBMET00924 | DBMET00924 | |
| 0.034 | 0.163 | 0.083 | Heat shock protein 90 beta antagonist | 0.083 0.018 DB00244 | DB00244 | |
| 0.059 | 0.19 | 0.091 | Hematopoietic | 0.088 0.053 DB00244 0.091 0.048 DBMET00924 | DBMET00924 | |
| 0.085 | 0.217 | 0.175 | Insulin secretagoues | 0.13 0.097 DB00244 0.175 0.052 DBMET03576 | DBMET03576 | |
| 0.038 | 0.17 | 0.492 | GABA aminotransferase inhibitor | 0.492 0.003 DB00244 0.157 0.007 DBMET00924 | DB00244 | |
| 0.027 | 0.16 | 0.083 | Leukotriene synthesis inhibitor | 0.083 0.035 DB00244 | DB00244 | |
| 0.011 | 0.144 | 0.057 | Factor Xa inhibitor | 0.057 0.025 DB00891 0.039 0.038 DBMET03575 0.05 0.029 DBMET03576 | DB00891 | |
| 0.036 | 0.169 | 0.117 | CDK/cyclin complex inhibitor | 0.117 0.043 DB00891 | DB00891 | |
| 0.017 | 0.151 | 0.071 | Glutamate (mGluR3) agonist | 0.071 0.003 DB00244 0.054 0.004 DBMET00924 | DB00244 | |
| 0.012 | 0.149 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | 0.048 0.042 DB00244 | DB00244 | |
| 0.094 | 0.23 | 0.367 | Antiamyloidogenic | 0.367 0.035 DB00244 0.267 0.064 DBMET00924 | DB00244 | |
| 0.038 | 0.178 | 0.104 | Ryanodine receptor antagonist | 0.104 0.004 DB00244 0.059 0.039 DBMET00924 | DB00244 | |
| 0.033 | 0.173 | 0.079 | Potassium channel (ATP-sensitive) blocker | 0.066 0.049 DB00244 0.079 0.029 DB00891 | DB00891 | |
| 0.074 | 0.213 | 0.222 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.171 0.101 DB00244 0.211 0.068 DB00891 0.135 0.134 DBMET00924 0.222 0.061 DBMET03575 | DBMET03575 | |
| 0.027 | 0.168 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.031 DBMET03576 | DBMET03576 | |
| 0.052 | 0.195 | 0.104 | Thioredoxin inhibitor | 0.093 0.057 DB00244 0.104 0.044 DBMET03576 | DBMET03576 | |
| 0.002 | 0.145 | 0.033 | Glutamate (mGluR6) agonist | 0.033 0.003 DB00244 0.015 0.006 DBMET00924 | DB00244 | |
| 0.056 | 0.2 | 0.131 | Protein kinase (CK1) gamma 2 inhibitor | 0.128 0.059 DB00891 0.131 0.058 DBMET03575 | DBMET03575 | |
| 0.014 | 0.158 | 0.128 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.09 0.019 DB00891 0.128 0.012 DBMET03575 | DBMET03575 | |
| 0.102 | 0.248 | 0.384 | Antioxidant | 0.352 0.046 DB00244 0.274 0.072 DBMET00924 0.384 0.038 DBMET03576 | DBMET03576 | |
| 0.011 | 0.157 | 0.049 | Ribonucleotide reductase inhibitor | 0.049 0.043 DB00244 | DB00244 | |
| 0.07 | 0.217 | 0.261 | Anticoagulant | 0.261 0.036 DBMET03576 | DBMET03576 | |
| 0.013 | 0.16 | 0.292 | NMDA 2A receptor antagonist | 0.292 0.004 DB00244 0.134 0.008 DBMET00924 | DB00244 | |
| 0.043 | 0.191 | 0.083 | Sphingosine 1-phosphate receptor antagonist | 0.083 0.041 DBMET00924 | DBMET00924 | |
| 0.011 | 0.161 | 0.029 | Vanilloid 2 agonist | 0.029 0.012 DB00244 | DB00244 | |
| 0.001 | 0.152 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DB00891 | DB00891 | |
| 0.01 | 0.162 | 0.094 | Retinoid X alpha receptor agonist | 0.094 0.005 DB00244 0.033 0.027 DBMET00924 | DB00244 | |
| 0.008 | 0.161 | 0.026 | Motilin receptor agonist | 0.026 0.012 DBMET03576 | DBMET03576 | |
| 0.018 | 0.171 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.02 DB00244 0.031 0.03 DBMET00924 | DB00244 | |
| 0.007 | 0.161 | 0.028 | Factor VII inhibitor | 0.028 0.023 DB00244 | DB00244 | |
| 0.073 | 0.227 | 0.132 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.132 0.112 DB00891 | DB00891 | |
| 0.026 | 0.18 | 0.08 | Factor IXa inhibitor | 0.062 0.025 DB00244 0.07 0.021 DBMET00924 0.08 0.016 DBMET03576 | DBMET03576 | |
| 0.053 | 0.208 | 0.185 | MAP kinase kinase inhibitor | 0.128 0.066 DB00244 0.185 0.034 DB00891 0.169 0.042 DBMET03575 | DB00891 | |
| 0.004 | 0.161 | 0.065 | Growth hormone secretagogue receptor agonist | 0.065 0.015 DB00891 | DB00891 | |
| 0.125 | 0.282 | 0.358 | Peptidyltransferase inhibitor | 0.199 0.1 DB00244 0.267 0.04 DBMET00924 0.358 0.011 DBMET03576 | DBMET03576 | |
| 0.066 | 0.223 | 0.176 | Histone deacetylase SIRT1 inhibitor | 0.138 0.072 DB00244 0.176 0.042 DBMET00924 | DBMET00924 | |
| 0.043 | 0.202 | 0.231 | Topoisomerase II inhibitor | 0.231 0.027 DB00244 0.149 0.05 DBMET00924 0.121 0.066 DBMET03576 | DB00244 | |
| 0.037 | 0.199 | 0.121 | AXL receptor tyrosine kinase inhibitor | 0.121 0.027 DB00891 0.094 0.045 DBMET03575 | DB00891 | |
| 0.079 | 0.241 | 0.335 | Platelet adhesion inhibitor | 0.161 0.095 DB00244 0.141 0.117 DBMET00924 0.335 0.023 DBMET03576 | DBMET03576 | |
| 0.024 | 0.187 | 0.077 | Glutamate receptor agonist | 0.077 0.056 DB00244 | DB00244 | |
| 0.079 | 0.243 | 0.184 | DNA repair enzyme inhibitor | 0.152 0.03 DB00244 0.119 0.073 DBMET00924 0.184 0.012 DBMET03576 | DBMET03576 | |
| 0.055 | 0.22 | 0.266 | Thrombolytic | 0.178 0.063 DB00244 0.146 0.085 DBMET00924 0.266 0.03 DBMET03576 | DBMET03576 | |
| 0.03 | 0.195 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | 0.062 0.038 DB00891 | DB00891 | |
| 0.014 | 0.182 | 0.027 | Complement factor 1s inhibitor | 0.027 0.013 DB00891 | DB00891 | |
| 0.009 | 0.177 | 0.031 | Caspase 2 inhibitor | 0.031 0.023 DBMET00924 | DBMET00924 | |
| 0.05 | 0.219 | 0.267 | Adenylate cyclase inhibitor | 0.267 0.017 DB00244 0.165 0.036 DBMET00924 | DB00244 | |
| 0.009 | 0.178 | 0.031 | Calcium-sensing receptor agonist | 0.029 0.015 DB00244 0.031 0.013 DBMET00924 | DBMET00924 | |
| 0.003 | 0.172 | 0.045 | Kainate receptor 1 antagonist | 0.045 0.006 DB00244 0.03 0.01 DBMET00924 | DB00244 | |
| 0.003 | 0.173 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 DBMET03576 | DBMET03576 | |
| 0.011 | 0.181 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.01 DB00244 0.023 0.02 DBMET00924 | DB00244 | |
| 0.028 | 0.2 | 0.229 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.229 0.007 DB00244 0.145 0.02 DBMET00924 | DB00244 | |
| 0.011 | 0.183 | 0.036 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.021 DBMET00924 | DBMET00924 | |
| 0.049 | 0.222 | 0.135 | MAP kinase 12 inhibitor | 0.135 0.054 DB00891 | DB00891 | |
| 0.01 | 0.183 | 0.097 | AMPA receptor antagonist | 0.097 0.013 DB00244 | DB00244 | |
| 0.021 | 0.195 | 0.106 | Phosphatidylinositol kinase inhibitor | 0.081 0.027 DB00891 0.106 0.019 DBMET03575 | DBMET03575 | |
| 0.016 | 0.191 | 0.125 | Dihydroorotase inhibitor | 0.065 0.014 DB00244 0.125 0.004 DBMET00924 | DBMET00924 | |
| 0.003 | 0.178 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | 0.012 0.011 DBMET00924 | DBMET00924 | |
| 0.019 | 0.195 | 0.051 | Glutamate (mGluR8) antagonist | 0.051 0.008 DB00244 0.035 0.026 DBMET00924 | DB00244 | |
| 0.013 | 0.189 | 0.07 | Thymidylate synthase inhibitor | 0.07 0.012 DB00244 | DB00244 | |
| 0.012 | 0.188 | 0.056 | Aromatase inhibitor | 0.056 0.044 DB00244 | DB00244 | |
| 0.015 | 0.191 | 0.165 | Dihydroorotate dehydrogenase inhibitor | 0.099 0.011 DB00244 0.165 0.005 DBMET00924 | DBMET00924 | |
| 0.083 | 0.261 | 0.248 | Platelet antagonist | 0.248 0.073 DBMET03576 | DBMET03576 | |
| 0.034 | 0.213 | 0.139 | Ornithine decarboxylase inhibitor | 0.139 0.015 DB00244 0.108 0.036 DBMET00924 | DB00244 | |
| 0.052 | 0.232 | 0.249 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.249 0.045 DB00891 0.232 0.051 DBMET03575 | DB00891 | |
| 0.017 | 0.198 | 0.12 | Neuraminidase (Influenza A) inhibitor | 0.069 0.008 DB00244 0.12 0.004 DBMET00924 | DBMET00924 | |
| 0.024 | 0.21 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.028 DB00244 | DB00244 | |
| 0.047 | 0.234 | 0.132 | MAP kinase kinase 1 inhibitor | 0.132 0.025 DB00244 0.131 0.026 DB00891 0.087 0.075 DBMET00924 0.131 0.026 DBMET03575 | DB00244 | |
| 0.05 | 0.238 | 0.236 | CDC-like kinase 2 inhibitor | 0.185 0.075 DB00891 0.236 0.05 DBMET03575 | DBMET03575 | |
| 0.034 | 0.224 | 0.13 | 5-Lipoxygenase inhibitor | 0.13 0.046 DB00244 0.083 0.078 DBMET00924 | DB00244 | |
| 0.044 | 0.236 | 0.257 | GABA C receptor antagonist | 0.257 0.006 DB00244 0.124 0.048 DBMET00924 | DB00244 | |
| 0.016 | 0.209 | 0.171 | 5 Hydroxytryptamine 6 antagonist | 0.171 0.005 DB00891 0.088 0.019 DBMET03575 | DB00891 | |
| 0.009 | 0.203 | 0.065 | Beta tubulin antagonist | 0.065 0.037 DB00244 | DB00244 | |
| 0.016 | 0.21 | 0.181 | Argininosuccinate synthase inhibitor | 0.181 0.009 DB00244 0.081 0.025 DBMET00924 | DB00244 | |
| 0.138 | 0.333 | 0.45 | Interleukin 2 agonist | 0.448 0.016 DB00244 0.45 0.015 DBMET00924 0.205 0.18 DBMET03575 0.391 0.03 DBMET03576 | DBMET00924 | |
| 0.036 | 0.233 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | 0.077 0.039 DB00244 0.07 0.054 DBMET00924 | DB00244 | |
| 0.016 | 0.214 | 0.074 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.074 0.023 DBMET03575 | DBMET03575 | |
| 0.132 | 0.33 | 0.283 | Caspase 3 stimulant | 0.283 0.088 DB00244 0.248 0.114 DBMET00924 | DB00244 | |
| 0.06 | 0.258 | 0.132 | TRKC antagonist | 0.132 0.118 DB00891 | DB00891 | |
| 0.05 | 0.249 | 0.161 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.161 0.059 DB00891 0.112 0.091 DBMET03575 | DB00891 | |
| 0.072 | 0.271 | 0.229 | Nitric oxide antagonist | 0.151 0.094 DB00244 0.133 0.114 DBMET00924 0.229 0.058 DBMET03576 | DBMET03576 | |
| 0.065 | 0.265 | 0.235 | LIM domain kinase 1 inhibitor | 0.194 0.066 DB00244 0.235 0.046 DB00891 0.145 0.103 DBMET00924 0.182 0.073 DBMET03575 | DB00891 | |
| 0.041 | 0.241 | 0.113 | Glutathione S-transferase inhibitor | 0.083 0.056 DB00244 0.113 0.027 DBMET00924 | DBMET00924 | |
| 0.003 | 0.206 | 0.066 | AMPA 1 receptor antagonist | 0.066 0.008 DB00244 0.034 0.018 DBMET00924 | DB00244 | |
| 0.167 | 0.37 | 0.638 | 5 Hydroxytryptamine release inhibitor | 0.568 0.016 DB00244 0.638 0.007 DBMET00924 | DBMET00924 | |
| 0.006 | 0.21 | 0.078 | Retinoid X receptor agonist | 0.078 0.008 DB00244 | DB00244 | |
| 0.052 | 0.257 | 0.14 | Cytokine production inhibitor | 0.13 0.079 DB00244 0.14 0.071 DBMET00924 | DBMET00924 | |
| 0.03 | 0.237 | 0.095 | Cyclin-dependent kinase 5 inhibitor | 0.095 0.079 DBMET03575 | DBMET03575 | |
| 0.028 | 0.237 | 0.086 | Check point kinase 2 inhibitor | 0.086 0.078 DB00891 | DB00891 | |
| 0.038 | 0.25 | 0.371 | Ferrochelatase inhibitor | 0.331 0.005 DB00244 0.371 0.004 DBMET00924 | DBMET00924 | |
| 0.053 | 0.266 | 0.192 | Aldehyde dehydrogenase inhibitor | 0.192 0.03 DB00244 0.104 0.092 DBMET00924 | DB00244 | |
| 0.03 | 0.245 | 0.088 | Pim-1 kinase inhibitor | 0.088 0.069 DB00244 | DB00244 | |
| 0.007 | 0.223 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.03 0.013 DB00244 0.034 0.009 DBMET00924 | DBMET00924 | |
| 0.126 | 0.343 | 0.625 | Histamine release inhibitor | 0.553 0.016 DB00244 0.625 0.008 DBMET00924 | DBMET00924 | |
| 0.041 | 0.258 | 0.148 | Bile acid receptor antagonist | 0.148 0.008 DB00244 0.126 0.015 DBMET00924 | DB00244 | |
| 0.009 | 0.227 | 0.129 | Phosphorylase inhibitor | 0.129 0.009 DB00244 0.098 0.013 DBMET00924 | DB00244 | |
| 0.188 | 0.407 | 0.489 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.456 0.058 DB00244 0.489 0.039 DBMET00924 | DBMET00924 | |
| 0.102 | 0.322 | 0.421 | DNA synthesis inhibitor | 0.421 0.019 DB00244 0.301 0.043 DBMET00924 0.238 0.075 DBMET03576 | DB00244 | |
| 0.034 | 0.255 | 0.062 | Kallikrein 7 inhibitor | 0.062 0.049 DBMET00924 | DBMET00924 | |
| 0.023 | 0.244 | 0.064 | MAP kinase kinase 9 inhibitor | 0.064 0.027 DB00891 | DB00891 | |
| 0.124 | 0.346 | 0.331 | Tyrosine 3 hydroxylase inhibitor | 0.331 0.021 DB00244 0.278 0.045 DBMET00924 | DB00244 | |
| 0.017 | 0.24 | 0.073 | CDC7 inhibitor | 0.073 0.041 DB00891 | DB00891 | |
| 0.054 | 0.279 | 0.153 | TRPA1 agonist | 0.141 0.038 DB00244 0.153 0.029 DBMET00924 | DBMET00924 | |
| 0.027 | 0.253 | 0.101 | MAP kinase kinase kinase inhibitor | 0.101 0.066 DB00891 | DB00891 | |
| 0.069 | 0.295 | 0.136 | Polo-like kinase-3 inhibitor | 0.136 0.102 DB00891 | DB00891 | |
| 0.017 | 0.249 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.075 0.023 DB00244 | DB00244 | |
| 0.008 | 0.24 | 0.023 | Caspase 8 inhibitor | 0.023 0.009 DBMET00924 | DBMET00924 | |
| 0.044 | 0.276 | 0.738 | Alpha-N-acetylglucosaminidase inhibitor | 0.467 0.006 DB00244 0.738 0.003 DBMET00924 | DBMET00924 | |
| 0.009 | 0.242 | 0.039 | CDK4/cyclin D3 inhibitor | 0.039 0.01 DB00891 0.026 0.023 DBMET03575 | DB00891 | |
| 0.061 | 0.295 | 0.179 | Cyclin-dependent kinase 8 inhibitor | 0.179 0.053 DB00891 0.178 0.053 DBMET03575 | DB00891 | |
| 0.069 | 0.303 | 0.247 | Hemostatic | 0.181 0.042 DB00244 0.174 0.046 DBMET00924 0.247 0.022 DBMET03576 | DBMET03576 | |
| 0.006 | 0.241 | 0.058 | Kainate receptor 2 antagonist | 0.058 0.012 DB00244 0.031 0.03 DBMET00924 | DB00244 | |
| 0.102 | 0.339 | 0.179 | Ca2+-transporting ATPase inhibitor | 0.179 0.007 DB00244 0.157 0.029 DBMET00924 | DB00244 | |
| 0.119 | 0.358 | 0.337 | Apoptosis antagonist | 0.337 0.062 DB00244 0.303 0.084 DBMET00924 0.32 0.073 DBMET03576 | DB00244 | |
| 0.01 | 0.252 | 0.083 | Glutamate (mGluR3) antagonist | 0.083 0.005 DB00244 0.034 0.03 DBMET00924 | DB00244 | |
| 0.036 | 0.277 | 0.157 | Anabolic | 0.157 0.014 DB00244 0.147 0.02 DBMET00924 | DB00244 | |
| 0.097 | 0.339 | 0.323 | Angiogenesis inhibitor | 0.204 0.165 DBMET00924 0.323 0.082 DBMET03576 | DBMET03576 | |
| 0.017 | 0.259 | 0.058 | Protein kinase C eta inhibitor | 0.058 0.036 DB00244 | DB00244 | |
| 0.049 | 0.292 | 0.087 | Phosphodiesterase 6D inhibitor | 0.087 0.083 DB00244 | DB00244 | |
| 0.074 | 0.319 | 0.207 | CF transmembrane conductance regulator agonist | 0.207 0.018 DB00244 0.187 0.03 DBMET00924 0.134 0.108 DBMET03575 | DB00244 | |
| 0.006 | 0.252 | 0.032 | AMPA 2 receptor antagonist | 0.032 0.019 DB00244 | DB00244 | |
| 0.084 | 0.331 | 0.316 | Thyroid hormone antagonist | 0.316 0.086 DBMET00924 | DBMET00924 | |
| 0.017 | 0.265 | 0.058 | mTOR inhibitor | 0.054 0.034 DB00891 0.058 0.03 DBMET03575 | DBMET03575 | |
| 0.008 | 0.257 | 0.092 | Ornithine carbamoyltransferase inhibitor | 0.092 0.018 DB00244 0.05 0.04 DBMET00924 | DB00244 | |
| 0.014 | 0.263 | 0.075 | Lysophosphatidic acid 3 receptor antagonist | 0.072 0.013 DB00244 0.075 0.011 DBMET00924 | DBMET00924 | |
| 0.027 | 0.276 | 0.127 | Histamine N-methyltransferase inhibitor | 0.127 0.025 DB00244 | DB00244 | |
| 0.004 | 0.253 | 0.07 | NMDA receptor glycine site antagonist | 0.051 0.005 DB00244 0.07 0.004 DBMET00924 | DBMET00924 | |
| 0.043 | 0.293 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | 0.134 0.009 DB00244 0.091 0.05 DBMET00924 | DB00244 | |
| 0.045 | 0.298 | 0.143 | Toll-Like receptor 4 antagonist | 0.119 0.045 DB00244 0.107 0.059 DBMET00924 0.143 0.025 DBMET03576 | DBMET03576 | |
| 0.008 | 0.262 | 0.28 | NMDA 2 receptor antagonist | 0.28 0.005 DB00244 0.153 0.016 DBMET00924 | DB00244 | |
| 0.029 | 0.284 | 0.111 | Potassium channel activator | 0.081 0.074 DB00244 0.111 0.038 DBMET00924 | DBMET00924 | |
| 0.013 | 0.269 | 0.079 | AMPA 4 receptor antagonist | 0.079 0.006 DB00244 | DB00244 | |
| 0.006 | 0.268 | 0.075 | Fumarate hydratase inhibitor | 0.075 0.008 DB00244 0.04 0.019 DBMET00924 | DB00244 | |
| 0.063 | 0.327 | 0.308 | Hepatoprotectant | 0.178 0.081 DB00244 0.143 0.117 DBMET00924 0.308 0.028 DBMET03576 | DBMET03576 | |
| 0.005 | 0.271 | 0.057 | AMPA 3 receptor antagonist | 0.057 0.007 DB00244 0.027 0.023 DBMET00924 | DB00244 | |
| 0.017 | 0.284 | 0.056 | Kainate receptor agonist | 0.056 0.009 DB00244 0.042 0.028 DBMET00924 | DB00244 | |
| 0.104 | 0.371 | 0.237 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.237 0.119 DB00891 0.209 0.147 DBMET03575 | DB00891 | |
| 0.016 | 0.284 | 0.036 | Potassium channel Kv1.1 blocker | 0.036 0.031 DB00891 | DB00891 | |
| 0.018 | 0.29 | 0.062 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 DB00244 0.048 0.033 DBMET00924 | DB00244 | |
| 0.02 | 0.295 | 0.102 | Topoisomerase II alpha inhibitor | 0.102 0.039 DB00244 0.093 0.044 DBMET00924 | DB00244 | |
| 0.008 | 0.285 | 0.034 | Glutamate (mGluR group II) agonist | 0.034 0.025 DB00244 | DB00244 | |
| 0.038 | 0.316 | 0.109 | MAP kinase kinase 7 inhibitor | 0.109 0.007 DB00244 0.094 0.019 DBMET00924 | DB00244 | |
| 0.006 | 0.285 | 0.028 | Glutamate (mGluR2) agonist | 0.028 0.026 DB00244 | DB00244 | |
| 0.032 | 0.312 | 0.27 | Mucolytic | 0.24 0.007 DB00244 0.27 0.005 DBMET00924 | DBMET00924 | |
| 0.035 | 0.315 | 0.113 | Estrogen receptor beta antagonist | 0.113 0.042 DB00244 0.1 0.065 DBMET00924 | DB00244 | |
| 0.017 | 0.298 | 0.09 | Histone deacetylase inhibitor | 0.09 0.023 DB00891 0.07 0.04 DBMET03575 | DB00891 | |
| 0.007 | 0.291 | 0.056 | Thyroid hormone agonist | 0.03 0.012 DB00244 0.056 0.004 DBMET00924 | DBMET00924 | |
| 0.036 | 0.32 | 0.146 | CDC-like kinase 4 inhibitor | 0.138 0.111 DB00891 0.146 0.104 DBMET03575 | DBMET03575 | |
| 0.028 | 0.315 | 0.119 | Vascular endothelial growth factor 3 antagonist | 0.119 0.095 DB00891 | DB00891 | |
| 0.029 | 0.318 | 0.072 | Exportin-1 inhibitor | 0.072 0.04 DB00891 | DB00891 | |
| 0.012 | 0.3 | 0.069 | Adenosine deaminase inhibitor | 0.069 0.014 DB00244 0.05 0.03 DBMET00924 | DB00244 | |
| 0.045 | 0.334 | 0.36 | Cyclooxygenase 3 inhibitor | 0.239 0.01 DB00244 0.36 0.004 DBMET00924 0.159 0.041 DBMET03576 | DBMET00924 | |
| 0.024 | 0.315 | 0.098 | Ca(v)2.2 blocker | 0.098 0.05 DB00891 | DB00891 | |
| 0.001 | 0.293 | 0.016 | Thyroid hormone beta agonist | 0.016 0.004 DBMET00924 | DBMET00924 | |
| 0.039 | 0.335 | 0.169 | Cathepsin H inhibitor | 0.169 0.035 DB00244 0.124 0.07 DBMET00924 | DB00244 | |
| 0.106 | 0.405 | 0.234 | Nitric-oxide synthase stimulant | 0.234 0.045 DB00244 0.18 0.129 DB00891 0.199 0.09 DBMET00924 0.202 0.085 DBMET03575 0.191 0.104 DBMET03576 | DB00244 | |
| 0.05 | 0.35 | 0.367 | Immunostimulant | 0.335 0.069 DB00244 0.351 0.064 DBMET00924 0.367 0.059 DBMET03576 | DBMET03576 | |
| 0.067 | 0.367 | 0.263 | 5 Hydroxytryptamine 1E antagonist | 0.263 0.061 DB00891 0.19 0.142 DBMET00924 0.217 0.111 DBMET03575 | DB00891 | |
| 0.08 | 0.381 | 0.195 | Death-associated protein kinase 2 inhibitor | 0.195 0.038 DBMET00924 | DBMET00924 | |
| 0.007 | 0.311 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.008 DB00244 0.017 0.016 DBMET00924 | DB00244 | |
| 0.042 | 0.346 | 0.121 | Estrogen antagonist | 0.121 0.054 DB00244 0.106 0.083 DBMET00924 | DB00244 | |
| 0.03 | 0.336 | 0.118 | Interleukin 1 beta converting enzyme inhibitor | 0.098 0.059 DB00244 0.118 0.037 DBMET00924 | DBMET00924 | |
| 0.036 | 0.342 | 0.37 | Aryl hydrocarbon receptor agonist | 0.37 0.043 DB00244 0.345 0.049 DBMET00924 | DB00244 | |
| 0.058 | 0.364 | 0.175 | Calpain inhibitor | 0.175 0.141 DBMET00924 | DBMET00924 | |
| 0.027 | 0.334 | 0.068 | Phosphodiesterase 1C inhibitor | 0.068 0.032 DB00244 0.06 0.049 DBMET00924 | DB00244 | |
| 0.027 | 0.336 | 0.088 | Histamine H2 receptor antagonist | 0.088 0.051 DB00244 | DB00244 | |
| 0.018 | 0.328 | 0.219 | NMDA receptor agonist | 0.192 0.005 DB00244 0.219 0.004 DBMET00924 | DBMET00924 | |
| 0.036 | 0.346 | 0.196 | DNA polymerase I inhibitor | 0.196 0.029 DB00244 0.151 0.048 DBMET00924 | DB00244 | |
| 0.032 | 0.342 | 0.132 | Cyclin-dependent kinase 7 inhibitor | 0.112 0.091 DB00891 0.132 0.074 DBMET03575 | DBMET03575 | |
| 0.065 | 0.377 | 0.212 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.176 0.111 DB00891 0.212 0.082 DBMET03575 | DBMET03575 | |
| 0.102 | 0.414 | 0.554 | GABA C receptor rho-3 antagonist | 0.554 0.014 DB00244 0.276 0.133 DB00891 0.366 0.078 DBMET00924 0.28 0.13 DBMET03575 | DB00244 | |
| 0.046 | 0.359 | 0.295 | Interleukin antagonist | 0.195 0.087 DB00244 0.295 0.049 DBMET00924 | DBMET00924 | |
| 0.047 | 0.361 | 0.106 | Interleukin 12 antagonist | 0.101 0.052 DB00244 0.106 0.045 DBMET00924 | DBMET00924 | |
| 0.004 | 0.318 | 0.038 | Lysine carboxypeptidase inhibitor | 0.038 0.011 DB00244 | DB00244 | |
| 0.073 | 0.387 | 0.211 | Papain-like protease (SARS coronavirus) inhibitor | 0.193 0.012 DB00244 0.211 0.008 DBMET00924 | DBMET00924 | |
| 0.04 | 0.356 | 0.514 | Angiogenesis stimulant | 0.307 0.047 DB00244 0.234 0.077 DBMET00924 0.514 0.011 DBMET03576 | DBMET03576 | |
| 0.01 | 0.326 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 DB00244 0.027 0.023 DBMET00924 | DB00244 | |
| 0.008 | 0.324 | 0.045 | CDK5/p25 inhibitor | 0.045 0.024 DBMET00924 | DBMET00924 | |
| 0.031 | 0.351 | 0.096 | Breast cancer-resistant protein inhibitor | 0.096 0.059 DB00244 | DB00244 | |
| 0.005 | 0.329 | 0.046 | Geranyltranstransferase inhibitor | 0.046 0.027 DB00244 | DB00244 | |
| 0.023 | 0.351 | 0.128 | Cholesterol synthesis inhibitor | 0.128 0.058 DB00244 0.102 0.085 DBMET00924 | DB00244 | |
| 0.014 | 0.343 | 0.063 | Myc inhibitor | 0.063 0.026 DBMET00924 | DBMET00924 | |
| 0.063 | 0.392 | 0.293 | Thyroid hormone beta antagonist | 0.293 0.092 DBMET00924 | DBMET00924 | |
| 0.018 | 0.348 | 0.054 | Fatty acid synthase inhibitor | 0.054 0.045 DBMET00924 | DBMET00924 | |
| 0.04 | 0.37 | 0.162 | Photosensitizer | 0.162 0.025 DB00244 0.132 0.045 DBMET00924 | DB00244 | |
| 0.029 | 0.36 | 0.151 | Clk dual-specificity kinase inhibitor | 0.151 0.113 DBMET03575 | DBMET03575 | |
| 0.032 | 0.364 | 0.303 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.246 0.01 DB00244 0.303 0.006 DBMET00924 | DBMET00924 | |
| 0.033 | 0.365 | 0.108 | MAP kinase 13 inhibitor | 0.108 0.069 DB00891 | DB00891 | |
| 0.015 | 0.348 | 0.074 | Epoxide hydrolase inhibitor | 0.074 0.049 DBMET00924 | DBMET00924 | |
| 0.037 | 0.37 | 0.088 | Interleukin 5 antagonist | 0.088 0.058 DB00244 0.081 0.07 DBMET00924 | DB00244 | |
| 0.009 | 0.342 | 0.145 | Acyl-CoA dehydrogenase inhibitor | 0.145 0.01 DB00244 0.09 0.019 DBMET00924 | DB00244 | |
| 0.027 | 0.36 | 0.113 | TRKA antagonist | 0.113 0.073 DB00891 | DB00891 | |
| 0.016 | 0.353 | 0.051 | Dopamine beta hydroxylase inhibitor | 0.051 0.029 DB00244 | DB00244 | |
| 0.01 | 0.349 | 0.061 | Cyclin A1 inhibitor | 0.061 0.037 DB00891 | DB00891 | |
| 0.026 | 0.366 | 0.074 | Neuropeptide Y antagonist | 0.074 0.068 DB00891 | DB00891 | |
| 0.068 | 0.41 | 0.229 | Sphingosine 1-phosphate receptor 5 antagonist | 0.191 0.016 DB00244 0.229 0.005 DBMET00924 | DBMET00924 | |
| 0.031 | 0.374 | 0.211 | Lipid peroxidase inhibitor | 0.211 0.037 DB00244 0.188 0.047 DBMET00924 0.151 0.068 DBMET03576 | DB00244 | |
| 0.029 | 0.373 | 0.243 | GABA C receptor rho-1 antagonist | 0.243 0.005 DB00244 0.124 0.036 DBMET00924 | DB00244 | |
| 0.005 | 0.35 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 DB00244 | DB00244 | |
| 0.004 | 0.35 | 0.033 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.02 DBMET00924 | DBMET00924 | |
| 0.019 | 0.368 | 0.091 | Glutamate (mGluR7) antagonist | 0.091 0.016 DB00244 0.062 0.06 DBMET00924 | DB00244 | |
| 0.04 | 0.389 | 0.121 | Nav1.2 sodium channel blocker | 0.121 0.082 DB00891 | DB00891 | |
| 0.023 | 0.372 | 0.096 | MAP kinase 9 inhibitor | 0.096 0.066 DB00891 | DB00891 | |
| 0.004 | 0.355 | 0.138 | NMDA receptor subunit 3A antagonist | 0.138 0.005 DB00244 0.059 0.017 DBMET00924 | DB00244 | |
| 0.078 | 0.429 | 0.222 | Antiobesity | 0.222 0.185 DBMET03576 | DBMET03576 | |
| 0.017 | 0.369 | 0.276 | Expectorant | 0.269 0.011 DB00244 0.276 0.01 DBMET00924 0.089 0.082 DBMET03576 | DBMET00924 | |
| 0.036 | 0.388 | 0.141 | Activin receptor-like kinase 2 inhibitor | 0.141 0.074 DB00891 0.12 0.096 DBMET03575 | DB00891 | |
| 0.004 | 0.363 | 0.05 | Leukotriene A4 hydrolase inhibitor | 0.049 0.02 DB00244 0.05 0.02 DBMET00924 | DBMET00924 | |
| 0.011 | 0.372 | 0.218 | Catalase inhibitor | 0.139 0.029 DB00244 0.218 0.012 DBMET00924 | DBMET00924 | |
| 0.027 | 0.388 | 0.117 | Glutamate (mGluR6) antagonist | 0.117 0.006 DB00244 0.079 0.025 DBMET00924 | DB00244 | |
| 0.025 | 0.386 | 0.1 | Cell adhesion molecule inhibitor | 0.1 0.035 DBMET03576 | DBMET03576 | |
| 0.057 | 0.42 | 0.29 | Calpain 2 inhibitor | 0.29 0.121 DBMET00924 | DBMET00924 | |
| 0.02 | 0.388 | 0.194 | Falcipain 3 inhibitor | 0.156 0.034 DB00244 0.194 0.019 DBMET00924 | DBMET00924 | |
| 0.033 | 0.401 | 0.084 | mTOR complex 2 inhibitor | 0.084 0.06 DB00244 | DB00244 | |
| 0.015 | 0.384 | 0.061 | Cyclin D1 inhibitor | 0.061 0.041 DB00244 0.058 0.046 DBMET00924 | DB00244 | |
| 0.008 | 0.379 | 0.058 | Nerve growth factor antagonist | 0.058 0.011 DB00244 0.044 0.027 DBMET00924 | DB00244 | |
| 0.052 | 0.424 | 0.241 | 3C-like protease (Human coronavirus) inhibitor | 0.162 0.084 DB00244 0.241 0.031 DBMET00924 | DBMET00924 | |
| 0.01 | 0.383 | 0.112 | Carbamoyl phosphate synthetase inhibitor | 0.112 0.017 DB00244 | DB00244 | |
| 0.046 | 0.42 | 0.135 | Transcription factor STAT6 inhibitor | 0.126 0.051 DB00244 0.135 0.038 DBMET00924 | DBMET00924 | |
| 0.008 | 0.383 | 0.054 | Dihydrofolate reductase inhibitor | 0.054 0.015 DB00244 | DB00244 | |
| 0.118 | 0.494 | 0.373 | Caspase 9 stimulant | 0.285 0.21 DB00244 0.373 0.128 DBMET00924 | DBMET00924 | |
| 0.075 | 0.454 | 0.336 | Vasodilator, peripheral | 0.253 0.125 DB00244 0.336 0.08 DBMET00924 | DBMET00924 | |
| 0.018 | 0.397 | 0.071 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.042 DB00244 0.071 0.027 DBMET00924 | DBMET00924 | |
| 0.036 | 0.417 | 0.215 | Arachidonic acid antagonist | 0.215 0.021 DB00244 0.18 0.054 DBMET00924 | DB00244 | |
| 0.008 | 0.389 | 0.029 | Estrogen-related receptor alpha antagonist | 0.029 0.027 DB00244 | DB00244 | |
| 0.051 | 0.432 | 0.184 | NOS3 expression enhancer | 0.131 0.096 DBMET00924 0.184 0.048 DBMET03576 | DBMET03576 | |
| 0.019 | 0.404 | 0.187 | Mediator release inhibitor | 0.156 0.026 DB00244 0.187 0.017 DBMET00924 | DBMET00924 | |
| 0.005 | 0.39 | 0.048 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 DB00244 0.048 0.003 DBMET00924 | DBMET00924 | |
| 0.009 | 0.395 | 0.262 | NMDA receptor antagonist | 0.262 0.008 DB00244 0.163 0.021 DBMET00924 | DB00244 | |
| 0.033 | 0.42 | 0.086 | Thioredoxin reductase inhibitor | 0.086 0.048 DB00244 0.077 0.072 DBMET00924 | DB00244 | |
| 0.046 | 0.435 | 0.228 | GABA C receptor rho-2 antagonist | 0.228 0.017 DB00244 0.146 0.079 DBMET00924 | DB00244 | |
| 0.008 | 0.397 | 0.177 | NMDA receptor glycine site agonist | 0.15 0.004 DB00244 0.177 0.004 DBMET00924 | DBMET00924 | |
| 0.012 | 0.402 | 0.121 | Androgen antagonist | 0.084 0.06 DB00244 0.121 0.033 DBMET00924 | DBMET00924 | |
| 0.032 | 0.424 | 0.104 | Calcium channel N-type blocker | 0.104 0.088 DB00891 | DB00891 | |
| 0.014 | 0.407 | 0.058 | Epithelial sodium channel blocker | 0.058 0.032 DB00244 | DB00244 | |
| 0.021 | 0.419 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.038 DBMET00924 | DBMET00924 | |
| 0.017 | 0.415 | 0.134 | Glutamate receptor antagonist | 0.134 0.062 DB00244 | DB00244 | |
| 0.017 | 0.415 | 0.056 | Pregnane X receptor antagonist | 0.056 0.042 DB00244 | DB00244 | |
| 0.013 | 0.415 | 0.065 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.043 DB00244 0.065 0.031 DBMET00924 | DBMET00924 | |
| 0.012 | 0.415 | 0.033 | ATR kinase inhibitor | 0.033 0.023 DB00891 | DB00891 | |
| 0.07 | 0.478 | 0.392 | Immunomodulator | 0.392 0.046 DBMET03576 | DBMET03576 | |
| 0.069 | 0.477 | 0.183 | Neurotensin receptor agonist | 0.181 0.049 DB00244 0.183 0.047 DBMET00924 | DBMET00924 | |
| 0.006 | 0.414 | 0.05 | GABA uptake inhibitor | 0.05 0.016 DB00244 | DB00244 | |
| 0.023 | 0.435 | 0.164 | Glycine receptor agonist | 0.164 0.005 DB00244 0.087 0.031 DBMET00924 | DB00244 | |
| 0.024 | 0.436 | 0.486 | Anesthetic general | 0.486 0.009 DB00244 0.36 0.022 DBMET00924 | DB00244 | |
| 0.008 | 0.422 | 0.306 | Selectin antagonist | 0.066 0.045 DBMET00924 0.306 0.005 DBMET03576 | DBMET03576 | |
| 0.005 | 0.42 | 0.151 | NMDA receptor subunit 3B antagonist | 0.151 0.006 DB00244 0.08 0.014 DBMET00924 | DB00244 | |
| 0.004 | 0.42 | 0.024 | Estrogen-related receptor gamma agonist | 0.024 0.006 DB00244 0.02 0.01 DBMET00924 | DB00244 | |
| 0.046 | 0.464 | 0.19 | Adenylate cyclase stimulant | 0.19 0.019 DB00244 0.133 0.095 DBMET00924 | DB00244 | |
| 0.115 | 0.535 | 0.494 | Calcium channel L-type activator | 0.494 0.03 DB00244 0.447 0.052 DBMET00924 | DB00244 | |
| 0.027 | 0.449 | 0.14 | Beta amyloid protein antagonist | 0.14 0.048 DB00244 | DB00244 | |
| 0.03 | 0.453 | 0.218 | Cell wall synthesis inhibitor | 0.218 0.024 DB00244 0.218 0.024 DBMET00924 0.152 0.064 DBMET03576 | DBMET00924 | |
| 0.015 | 0.441 | 0.152 | Alkylator | 0.152 0.045 DB00244 0.112 0.075 DBMET00924 | DB00244 | |
| 0.079 | 0.506 | 0.399 | Calcium channel activator | 0.399 0.025 DB00244 0.301 0.091 DBMET00924 | DB00244 | |
| 0.052 | 0.481 | 0.346 | Immunosuppressant | 0.245 0.152 DB00244 0.205 0.192 DBMET00924 0.346 0.089 DBMET03576 | DBMET03576 | |
| 0.047 | 0.476 | 0.168 | Tumour necrosis factor antagonist | 0.168 0.078 DB00244 | DB00244 | |
| 0.002 | 0.434 | 0.017 | 5-Alpha-reductase 1 inhibitor | 0.017 0.012 DBMET00924 | DBMET00924 | |
| 0.004 | 0.437 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 DBMET00924 | DBMET00924 | |
| 0.035 | 0.468 | 0.158 | Sphingosine 1-phosphate receptor 4 antagonist | 0.121 0.071 DB00244 0.158 0.027 DBMET00924 | DBMET00924 | |
| 0.012 | 0.45 | 0.128 | Protein kinase C zeta inhibitor | 0.128 0.028 DB00244 | DB00244 | |
| 0.031 | 0.469 | 0.169 | Cell adhesion inhibitor | 0.169 0.036 DBMET03576 | DBMET03576 | |
| 0.04 | 0.479 | 0.215 | Interleukin 6 antagonist | 0.215 0.033 DB00244 0.157 0.079 DB00891 0.135 0.114 DBMET03575 0.2 0.041 DBMET03576 | DB00244 | |
| 0.005 | 0.443 | 0.057 | Dopamine D5 agonist | 0.057 0.013 DB00244 | DB00244 | |
| 0.059 | 0.503 | 0.328 | Gastrin inhibitor | 0.295 0.036 DB00244 0.328 0.018 DBMET00924 | DBMET00924 | |
| 0.004 | 0.45 | 0.051 | Guanylate cyclase inhibitor | 0.051 0.02 DB00244 | DB00244 | |
| 0.037 | 0.486 | 0.108 | Estrogen-related receptor beta agonist | 0.108 0.017 DB00244 0.088 0.045 DBMET00924 | DB00244 | |
| 0.008 | 0.463 | 0.04 | Membrane dipeptidase inhibitor | 0.04 0.026 DB00244 | DB00244 | |
| 0.003 | 0.461 | 0.039 | 5-Alpha-reductase inhibitor | 0.032 0.031 DB00244 0.039 0.025 DBMET00924 | DBMET00924 | |
| 0.024 | 0.484 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.056 0.033 DB00244 | DB00244 | |
| 0.002 | 0.464 | 0.05 | Arginase inhibitor | 0.05 0.015 DB00244 | DB00244 | |
| 0.032 | 0.498 | 0.157 | Neuropeptide Y1 antagonist | 0.157 0.055 DB00244 0.15 0.065 DBMET00924 | DB00244 | |
| 0.04 | 0.509 | 0.187 | Glutamate release inhibitor | 0.187 0.005 DB00244 0.086 0.072 DBMET00924 | DB00244 | |
| 0.024 | 0.494 | 0.161 | Antibacterial (Helicobacter pylori) | 0.12 0.081 DB00244 0.161 0.038 DBMET00924 | DBMET00924 | |
| 0.017 | 0.487 | 0.123 | Microtubule formation inhibitor | 0.123 0.057 DB00244 0.105 0.082 DBMET00924 | DB00244 | |
| 0.013 | 0.489 | 0.061 | Sirtuin 1 inhibitor | 0.061 0.058 DBMET00924 | DBMET00924 | |
| 0.097 | 0.573 | 0.184 | 5 Hydroxytryptamine 3E antagonist | 0.184 0.095 DB00891 0.17 0.134 DBMET00924 | DB00891 | |
| 0.011 | 0.487 | 0.072 | Protein kinase C beta inhibitor | 0.072 0.043 DB00244 | DB00244 | |
| 0.009 | 0.498 | 0.251 | Anesthetic local | 0.251 0.02 DB00244 0.183 0.037 DBMET00924 | DB00244 | |
| 0.039 | 0.528 | 0.179 | DNA damaging | 0.179 0.135 DB00244 | DB00244 | |
| 0.039 | 0.528 | 0.295 | Cyclic AMP phosphodiesterase inhibitor | 0.295 0.044 DB00244 0.23 0.074 DBMET00924 | DB00244 | |
| 0.006 | 0.498 | 0.055 | Mannosidase inhibitor | 0.055 0.02 DB00244 0.042 0.036 DBMET00924 | DB00244 | |
| 0.023 | 0.517 | 0.242 | Protein kinase stimulant | 0.242 0.029 DB00244 0.209 0.038 DBMET00924 | DB00244 | |
| 0.005 | 0.502 | 0.073 | NMDA 2B receptor antagonist | 0.073 0.024 DBMET03575 | DBMET03575 | |
| 0.034 | 0.532 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | 0.086 0.053 DBMET00924 | DBMET00924 | |
| 0.027 | 0.528 | 0.086 | Lanosterol 14 alpha demethylase inhibitor | 0.086 0.079 DB00891 | DB00891 | |
| 0.017 | 0.526 | 0.052 | Sodium/calcium exchanger inhibitor | 0.052 0.029 DB00244 | DB00244 | |
| 0.001 | 0.512 | 0.026 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.02 DB00244 | DB00244 | |
| 0.047 | 0.559 | 0.139 | Growth hormone agonist | 0.139 0.097 DBMET00924 | DBMET00924 | |
| 0.033 | 0.549 | 0.166 | Melanin inhibitor | 0.166 0.063 DB00244 0.157 0.073 DBMET00924 | DB00244 | |
| 0.004 | 0.522 | 0.238 | NMDA 2C receptor antagonist | 0.238 0.005 DB00244 0.118 0.011 DBMET00924 | DB00244 | |
| 0.051 | 0.575 | 0.244 | Vasodilator, coronary | 0.239 0.146 DB00244 0.244 0.14 DBMET03576 | DBMET03576 | |
| 0.04 | 0.567 | 0.296 | Neurotrophic factor enhancer | 0.296 0.019 DB00244 0.218 0.06 DBMET00924 | DB00244 | |
| 0.004 | 0.536 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.026 DB00244 0.027 0.026 DBMET00924 | DB00244 | |
| 0.009 | 0.543 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.078 0.02 DBMET03576 | DBMET03576 | |
| 0.006 | 0.547 | 0.069 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 DB00244 | DB00244 | |
| 0.022 | 0.564 | 0.099 | Acetylcholine release stimulant | 0.099 0.09 DB00244 | DB00244 | |
| 0.025 | 0.579 | 0.17 | Vasodilator | 0.157 0.147 DB00244 0.17 0.132 DBMET03576 | DBMET03576 | |
| 0.021 | 0.578 | 0.07 | MDM2 inhibitor | 0.07 0.039 DB00244 | DB00244 | |
| 0.036 | 0.599 | 0.119 | Vanilloid 1 agonist | 0.113 0.105 DB00244 0.119 0.091 DBMET00924 | DBMET00924 | |
| 0.003 | 0.567 | 0.033 | Epoxide hydrolase 1 inhibitor | 0.033 0.019 DBMET00924 | DBMET00924 | |
| 0.036 | 0.605 | 0.256 | Neuropeptide Y2 antagonist | 0.202 0.116 DB00244 0.256 0.051 DBMET00924 | DBMET00924 | |
| 0.012 | 0.587 | 0.076 | Interferon inducer | 0.076 0.027 DB00244 | DB00244 | |
| 0.004 | 0.584 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET03576 | DBMET03576 | |
| 0.01 | 0.594 | 0.089 | Topoisomerase I inhibitor | 0.087 0.082 DB00244 0.089 0.08 DBMET03576 | DBMET03576 | |
| 0.015 | 0.609 | 0.19 | Sphingosine 1-phosphate receptor 2 antagonist | 0.153 0.037 DB00244 0.19 0.01 DBMET00924 | DBMET00924 | |
| 0.004 | 0.602 | 0.081 | Antineoplastic antibiotic | 0.081 0.057 DBMET03576 | DBMET03576 | |
| 0.006 | 0.606 | 0.086 | Inducible nitric-oxide synthase inhibitor | 0.086 0.052 DB00244 | DB00244 | |
| 0.006 | 0.613 | 0.057 | Alpha-mannosidase inhibitor | 0.057 0.032 DB00244 | DB00244 | |
| 0.074 | 0.69 | 0.214 | ErbB-1 antagonist | 0.214 0.075 DB00244 | DB00244 | |
| 0.009 | 0.632 | 0.102 | Interferon agonist | 0.102 0.027 DB00244 | DB00244 | |
| 0.028 | 0.663 | 0.479 | Interleukin agonist | 0.433 0.014 DB00244 0.479 0.01 DBMET00924 | DBMET00924 | |
| 0.007 | 0.656 | 0.104 | Nitric-oxide synthase inhibitor | 0.104 0.054 DB00244 | DB00244 | |
| 0.012 | 0.681 | 0.167 | Toll-Like receptor 2 antagonist | 0.123 0.075 DB00244 0.167 0.041 DBMET00924 | DBMET00924 | |
| 0.047 | 0.727 | 0.213 | 5 Hydroxytryptamine release stimulant | 0.213 0.111 DB00244 | DB00244 | |
| 0.011 | 0.697 | 0.119 | Acetylcholine M1 receptor antagonist | 0.119 0.109 DB00244 | DB00244 | |
| 0.004 | 0.696 | 0.059 | Androgen agonist | 0.058 0.044 DB00244 0.059 0.043 DBMET00924 | DBMET00924 | |
| 0.004 | 0.707 | 0.057 | Sphingosine kinase inhibitor | 0.054 0.052 DB00244 0.057 0.044 DBMET00924 | DBMET00924 | |
| 0.006 | 0.717 | 0.105 | Glycine receptor antagonist | 0.105 0.028 DBMET00924 | DBMET00924 | |
| 0.018 | 0.77 | 0.089 | Glutamate (mGluR7) agonist | 0.089 0.088 DBMET00924 | DBMET00924 | |
| 0.01 | 0.791 | 0.213 | Tumour necrosis factor alpha release inhibitor | 0.213 0.098 DBMET03576 | DBMET03576 | |
| 0.007 | 0.81 | 0.06 | Antibiotic Aminoglycoside-like | 0.06 0.009 DBMET03576 | DBMET03576 | |
| 0.005 | 0.817 | 0.18 | Spasmolytic | 0.18 0.137 DB00244 | DB00244 | |
| 0.023 | 0.87 | 0.227 | Sigma receptor agonist | 0.227 0.054 DB00244 | DB00244 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |